<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56697</article-id><article-id pub-id-type="doi">10.7554/eLife.56697</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Trait-associated noncoding variant regions affect <italic>TBX3</italic> regulation and cardiac conduction</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-180293"><name><surname>van Weerd</surname><given-names>Jan Hendrik</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7955-8477</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180294"><name><surname>Mohan</surname><given-names>Rajiv A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3622-1759</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160858"><name><surname>van Duijvenboden</surname><given-names>Karel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180295"><name><surname>Hooijkaas</surname><given-names>Ingeborg B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180296"><name><surname>Wakker</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180297"><name><surname>Boukens</surname><given-names>Bastiaan J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180298"><name><surname>Barnett</surname><given-names>Phil</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-178004"><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4131-2636</contrib-id><email>v.m.christoffels@amsterdamumc.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution>Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name><role>Reviewing Editor</role><aff><institution>University of Chicago</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution>Max Planck Institute for Heart and Lung Research</institution><country>Germany</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>16</day><month>07</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e56697</elocation-id><history><date date-type="received" iso-8601-date="2020-03-06"><day>06</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-28"><day>28</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, van Weerd et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>van Weerd et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56697-v1.pdf"/><abstract><p>Genome-wide association studies have implicated common genomic variants in the gene desert upstream of <italic>TBX3</italic> in cardiac conduction velocity. Whether these noncoding variants affect expression of <italic>TBX3</italic> or neighboring genes and how they affect cardiac conduction is not understood. Here, we use high-throughput STARR-seq to test the entire 1.3 Mb human and mouse <italic>TBX3</italic> locus, including two cardiac conduction-associated variant regions, for regulatory function. We identified multiple accessible and functional regulatory DNA elements that harbor variants affecting their activity. Both variant regions drove gene expression in the cardiac conduction tissue in transgenic reporter mice. Genomic deletion from the mouse genome of one of the regions caused increased cardiac expression of only <italic>Tbx3,</italic> PR interval shortening and increased QRS duration. Combined, our findings address the mechanistic link between trait-associated variants in the gene desert, <italic>TBX3</italic> regulation and cardiac conduction.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>transcriptional regulation</kwd><kwd>epigenomics</kwd><kwd>enhancer</kwd><kwd>SNP</kwd><kwd>CRISPR/Cas9</kwd><kwd>atrioventricular conduction system</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002996</institution-id><institution>Dutch Heart Foundation</institution></institution-wrap></funding-source><award-id>CVON project CONCOR genes</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002996</institution-id><institution>Dutch Heart Foundation</institution></institution-wrap></funding-source><award-id>COBRA3</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001674</institution-id><institution>Fondation Leducq</institution></institution-wrap></funding-source><award-id>14CVD01</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M.</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002996</institution-id><institution>Dutch Heart Foundation</institution></institution-wrap></funding-source><award-id>2016T047</award-id><principal-award-recipient><name><surname>Boukens</surname><given-names>Bastiaan J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Multiple variant transcriptional regulatory elements in &gt;1 megabasepairs of noncoding DNA close to <italic>TBX3</italic> affect gene expression and atrioventricular conduction system function in vivo.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Genome-wide association studies (GWAS) increasingly implicate common variation in the human genome with traits and complex diseases, including traits reflecting cardiac conduction properties. The majority of trait-associated genetic variants (single nucleotide polymorphisms; SNPs) is found in noncoding genomic DNA, and is thought to affect the function of <italic>cis-</italic>regulatory elements (REs) controlling the activity of their target gene promoters (<xref ref-type="bibr" rid="bib24">Deplancke et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Maurano et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Schaub et al., 2012</xref>). Expression quantitative trait locus (eQTL) analyses show that common variation can lead to both down- and upregulation of target gene expression (<xref ref-type="bibr" rid="bib31">Gutierrez and Chung, 2016</xref>; <xref ref-type="bibr" rid="bib37">Hsu et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Roselli et al., 2018</xref>). Yet, the mechanisms underlying the effect of such variation on RE function and gene expression are poorly understood.</p><p>The atrioventricular conduction system (AVCS) conducts the electrical impulse from atria to ventricles and synchronizes ventricular activation, thus orchestrating the rhythm of the heart. Disrupted AVCS function can lead to life-threatening cardiac arrhythmias and hypertrophy (<xref ref-type="bibr" rid="bib2">Aeschbacher et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Cheng et al., 2009</xref>). Common SNPs in the gene desert upstream of <italic>TBX3</italic> have been strongly associated with both PR interval and QRS duration (<xref ref-type="bibr" rid="bib61">Pfeufer et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Sotoodehnia et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>; <xref ref-type="bibr" rid="bib83">Verweij et al., 2014</xref>), ECG parameters directly reflective of AVCS function and representing the time between the first moment of activation of the atria and the ventricles, and ventricular activation, respectively. The T-box transcription factor 3 (Tbx3) is specifically expressed in the AVCS, including the AV node, AV bundle and proximal bundle branches, and plays a critical role in its development and function (<xref ref-type="bibr" rid="bib8">Bakker et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Bakker et al., 2008</xref>; <xref ref-type="bibr" rid="bib26">Frank et al., 2011</xref>; <xref ref-type="bibr" rid="bib73">Singh et al., 2012</xref>). Presumably, the SNPs upstream of <italic>TBX3</italic> affect the expression of <italic>TBX3</italic> or other nearby genes, such as <italic>TBX5</italic>, which also plays a key role in AVCS development and function (<xref ref-type="bibr" rid="bib5">Arnolds et al., 2012</xref>; <xref ref-type="bibr" rid="bib15">Burnicka-Turek et al., 2020</xref>), or <italic>MED13L</italic>, encoding a subunit of the ubiquitously expressed Mediator complex involved in transcriptional activation (<xref ref-type="bibr" rid="bib6">Asadollahi et al., 2013</xref>; <xref ref-type="bibr" rid="bib80">van Haelst et al., 2015</xref>) and recently implicated in heart rate recovery after exercise (<xref ref-type="bibr" rid="bib65">RamÃ­rez et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Verweij et al., 2018</xref>).</p><p>Efforts to elucidate the mechanisms underlying the transcriptional regulation of AVCS genes and the role of genetic variation are challenging, as the availability of relevant cells for functional and (epi)genomic experiments is hampered by the very small proportion of <italic>TBX3</italic><sup>+</sup> AVCS cardiomyocytes in the heart and the heterogeneous cellular composition of the AVCS (<xref ref-type="bibr" rid="bib1">Aanhaanen et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Hoogaars et al., 2004</xref>). Along this line, eQTL data for <italic>TBX3</italic> in cardiac tissue is not available, and AVCS tissue from human hearts is not expected to become available soon. Moreover, suitable AVCS-like cell lines, derived from stem cells or immortalized primary cells do not exist. Current cardiac epigenomic datasets from humans are mainly derived from whole heart or heart compartment tissue and are not suitable for the identification of AVCS REs, as the proportion of AVCS cells in these tissues is extremely small.</p><p>In this study, we aimed at circumventing the unavailability of AVCS cells to elucidate how the PR interval- and QRS duration-associated variants in the gene desert in-between <italic>TBX3</italic> and <italic>MED13L</italic> affect the regulation of gene expression and AVCS function. Utilizing mouse AVCS-specific assay for transposase-accessible chromatin sequencing (ATAC-seq) and human and mouse <italic>TBX3/TBX5</italic> locus-wide self-transcribing active regulatory region sequencing (STARR-seq), we identified multiple regulatory regions within two risk loci upstream of <italic>TBX3</italic> that are activated by factors involved in AVCS development and drive gene expression in vitro. We assessed the presence of associated variants in these REs and tested their effect on RE activity. Using modified BACs containing the mouse orthologues of the respective risk loci, we show that each region independently drives reporter expression in the AVCS in transgenic mice. We deleted the mouse homologous regions of both human risk loci using CRISPR/Cas9-mediated genome editing and show that deletion of the proximal domain resulted in a two-fold increase in the expression of <italic>Tbx3,</italic> but not <italic>Tbx5</italic> or <italic>Med13l,</italic> specifically in the AVCS, and in decreased PR interval and increased QRS duration. Thus, we used a systematic approach to identify REs driving <italic>TBX3</italic> expression in the small number of cells that make up the AVCS, and provide evidence that a genomic noncoding region associated with PR interval is involved in the regulation of <italic>Tbx3</italic> expression and AVCS function in vivo.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>GWAS variation in gene desert upstream of TBX3</title><p>Common genomic variants associated with PR interval and QRS duration have been identified in the region of the human <italic>TBX3/TBX5</italic> gene cluster (<xref ref-type="bibr" rid="bib61">Pfeufer et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Sotoodehnia et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>). Using publicly available human Hi-C data, we defined the topologically associating domain (TAD) of this gene cluster. <italic>TBX3</italic> and its upstream gene desert are organized in a TAD of approximately 1.3 Mb that is delimited by binding sites for CCCTC-binding factor (CTCF; a zinc-finger protein associated with enhancer-promoter looping and TAD boundary formation [<xref ref-type="bibr" rid="bib23">de Wit et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Nora et al., 2017</xref>]) and physically separated from that of the neighboring gene <italic>MED13L,</italic> corresponding to the organization of the murine loci in cardiac embryonic tissue (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Sequences within the TADs of <italic>TBX3</italic> and <italic>TBX5</italic> physically interact with each other to some extent. To delineate the GWAS risk loci, we mapped the associated variants to the human reference genome. Variants associated with both PR interval (<xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>) and QRS duration (<xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>) are located in a region approximately â261 kb to â221 kb upstream of <italic>TBX3</italic> (variant region (VR) 1). A second region (VR2) ranging from â85 kb to â6 kb upstream of <italic>TBX3</italic> harbors SNPs associated with only PR interval. SNPs associated with QRS duration were also found downstream of <italic>TBX3.</italic> The location of these variants within the <italic>TBX3</italic> TAD suggests that they may affect putative REs that regulate the expression of <italic>TBX3</italic> and possibly <italic>TBX5</italic> in the heart, causing affected conduction parameters.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Identification of AVCS-specific accessible chromatin within the <italic>Tbx3</italic> locus harboring GWAS-associated variant regions.</title><p>(<bold>A</bold>) UCSC genome browser view depicts the genomic location of human <italic>TBX3</italic> and neighboring genes. GWAS SNPs associated with PR interval (<xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>) and QRS duration (<xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>) are plotted as âlog10 of their p-values (lower cut-off 1.3 (p=0.05)) and depict two variant regions (VR1 and VR2) upstream of <italic>TBX3</italic>. CTCF ChIP-seq track shows binding sites for CTCF, corresponding to the boundaries of the topologically associating domains. The Hi-C map is derived from a human lymphoblastoid cell line (<xref ref-type="bibr" rid="bib66">Rao et al., 2014</xref>) and reveals separated domains for <italic>TBX3</italic> and neighboring <italic>MED13L</italic> and <italic>TBX5</italic> (dark grey dashed lines). Within the <italic>TBX3/TBX5</italic> TAD, the <italic>TBX3</italic> and <italic>TBX5</italic> loci form sub-TADs (light grey dashed lines). (<bold>B</bold>) Genome browser view depicting embryonic Tbx3<sup>+</sup> AVCS-specific (ATAC_AVCS) and ventricular (ATAC Ventricle) accessible chromatin regions (<xref ref-type="bibr" rid="bib78">van Duijvenboden et al., 2019</xref>) within the murine <italic>Tbx3</italic> locus. AVCS and Ventricle RE candidates depict selected ATAC regions. (<bold>C</bold>) HOMER motif enrichment analysis on 67 AVCS and Ventricle ATAC regions (depicted in <bold>B</bold>) reveals binding motifs for Smad, Gata and Tcf factors are enriched in AV junction accessible regions compared to ventricular accessible regions. (<bold>D</bold>) Overlap of 67 ATAC_AVJ regions within <italic>Tbx3</italic> locus with 67 ATAC-ventricle regions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig1-v1.tif"/></fig></sec><sec id="s2-2"><title>Identification of accessible regulatory elements within the murine Tbx3 locus</title><p>To identify REs driving <italic>Tbx3</italic> expression in the AVCS that are possibly affected by genetic variation within VR1 and VR2, we performed ATAC-seq (assay for transposase-accessible chromatin, followed by sequencing) (<xref ref-type="bibr" rid="bib14">Buenrostro et al., 2013</xref>) on <italic>Tbx3</italic>+ FACS-purified AVCS cardiomyocytes from murine E13.5 <italic>Tbx3</italic><sup>Venus/+</sup> microdissected AV junctions. 67 genomic regions within the <italic>Tbx3/Tbx5</italic> regulatory domain, as determined by chromatin conformation capture (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>), are accessible in AVCS cardiomyocytes, including the previously identified AV canal enhancers Tbx3-eA and Tbx3-eB (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). To identify transcription factors potentially involved in the regulation of <italic>Tbx3</italic> in the AVCS, we performed a motif enrichment analysis on the 67 regions within the <italic>Tbx3</italic> locus and compared it to the analysis of an equal number of accessible regions in ventricular tissue within the locus (<xref ref-type="bibr" rid="bib78">van Duijvenboden et al., 2019</xref>). Among the highest scoring binding motifs in embryonic AVCS cells are motifs for transcription factors important for cardiogenesis, including Hand2, Sox9 and Tbx20 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Interestingly, AVCS-specific accessible sequences were enriched for motifs for members of the Smad and Gata families of transcription factors (Smad2-4, Gata4/6), involved in the activation of regulatory sequences (including Tbx3-eA) specifically in the AV canal (<xref ref-type="bibr" rid="bib75">Stefanovic et al., 2014</xref>), and for Tcf factors (Tcf4, Tcf3) acting downstream of canonical Wnt-signaling to regulate AV canal specification (<xref ref-type="bibr" rid="bib28">Gillers et al., 2015</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 1). Of the 67 AVCS regions, 28 overlapped with accessible ventricular regions (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Analysis of enriched motifs in the 39 AVCS- or ventricle-specific regions did not result in more pronounced tissue-specificity (not shown), prompting us to continue with the 67 AVCS regions for further analysis.</p></sec><sec id="s2-3"><title>Identification of active regulatory sequences in the mouse and human TBX3 locus</title><p>The lack of AVCS-specific epigenomic datasets from mouse or human tissue and the absence of readily available human AVCS-relevant cells hamper efforts to identify relevant REs. To overcome this deficit, we utilized our finding that AVCS-accessible regions within the <italic>Tbx3</italic> locus are enriched for binding sites for Smad/Gata and Tcf (Wnt) transcription factor binding, involved in AVCS gene regulation (<xref ref-type="bibr" rid="bib28">Gillers et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Stefanovic et al., 2014</xref>). Using bacterial artificial chromosomes (BACs) spanning the entire human (+ / - 1.3 Mb; 17 BACs) and murine (+ / - 1 Mb; 11 BACs) <italic>TBX3</italic> locus, we performed self-transcribing active regulatory region-sequencing (STARR-seq) (<xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref>) to scan for regulatory potential locus-wide (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The sequenced input libraries revealed an evenly distributed coverage throughout the locus, indicating that the entire locus is sufficiently and to an equal extent represented in the libraries (DNA input; <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). Regions where two BACs overlap show an approximate doubling of the number of sequencing reads.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Validation and characterization of STARR-seq datasets.</title><p>(<bold>A</bold>) Overview of the STARR-seq procedure on the murine/human <italic>TBX3/TBX5</italic> locus. BACs spanning the entire murine or human <italic>TBX3/TBX5</italic> locus are sheared to fragments of approximately 500â1000 bp. Fragments are recombined in the pSTARR expression vector to generate the STARR-seq libraries, which are transfected in cells with or without stimulation, thatÂ is with pcDNA (control) or expression vectors for Smad/Gata or Tcf factors. Two days after transfection, total RNA is isolated from all cells. mRNA transcripts are isolated from the pool of total RNA and next-generation sequenced on an Illumina MiSeq. Reads are mapped to the respective genomes. Comparison of stimulated over control data yields stimulus-responsive REs. (<bold>B</bold>) Overview of the human <italic>TBX3/TBX5</italic> locus with STARR-seq tracks for hSTARR_SG4 (SG4-vs-ctrl) and hSTARR_Wnt (Wnt-vs-ctrl). The displayed tracks represent log2 fold changes of enrichment of SG4/Wnt-stimulated regions over the unstimulated control. (<bold>C,D</bold>) Functional conservation of STARR-seq activity between murine and human fragments. Overlap of translated (mm9 to hg19) mSTARR_SG4 (160/216) (<bold>C</bold>) or mSTARR_Wnt (172/253) (<bold>D</bold>) regions with human hSTARR_SG4/Wnt regions. (<bold>E</bold>) Correlation between STARR-seq activities of replicate hSTARR_SG4 transfections in COS-7 cells. X- and y-axis depict log2 of the fold change of replicate 1 and replicate 2, respectively. (<bold>F</bold>) Genome browser views of hSTARR tracks for replicate transfections of libraries in COS-7 cells with co-transfection of SG4 factors show reproducibility of STARR-seq data. (<bold>G</bold>) Validation of selected active (log2FCÂ &gt;0.58 (FCÂ &gt;1.5)) hSTARR (nÂ =Â 10), mSTARR (nÂ =Â 9) and negative h/mSTARR (FCÂ &lt;1.5; nÂ =Â 10) regions by luciferase assay. Y-axis represents percentage of tested fragments with activity in luciferase assay (FCÂ &gt;2 of reporter activity over empty vector). (<bold>H</bold>) Relative luciferase activity (RLA) of pGL4-(Tbx2)<sub>4</sub> (top) and the ratio of luciferase activity of TOP over FOP reporter (bottom) upon co-transfection with pcDNA (â-â) and SG4- and Tcf-factors, respectively. Transfection in COS-7 cells; nÂ =Â 4. (<bold>I,J</bold>) Overlap of mSTARR_SG4/Wnt regions with ATAC_AVCS regions (<bold>I</bold>) and of hSTARR_SG4/Wnt with hEMERGE regions (<bold>J</bold>). (<bold>K</bold>) HOMER motif enrichment analysis on human and murine STARR_SG4 and STARR_Wnt active (log2FCÂ &gt;0/58 (FCÂ &gt;1.5)) regions. Binding motifs for Smad/Gata factors are generally more enriched in STARR_SG4 regions, whereas STARR_Wnt regions are more enriched for motifs for Tcf factors in both human and murine datasets.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>Overview of STARR-seq results in the human <italic>TBX3/TBX5</italic> locus.</title><p>16 BACs spanning the entire <italic>TBX3/TBX5</italic> locus were used to capture genomic fragments to generate STARR-seq libraries. Sequencing of the input library (DNA input) reveals an even coverage throughout the locus, indicating the entire locus is sufficiently represented in the library. Domains where two input BACs overlap can be recognized by an approximate doubling of the number of reads. Sequencing of RNA isolated after transfection of the input library in COS7 cells without stimulation (RNA control) shows regions that activate reporter gene expression in COS7 cells. RNA_SG4 track shows additional peaks, indicating regions stimulated by Smad/Gata factors. SG4Â &gt;Control depicts the log2 fold change of RNA_SG4 reads over RNA_control reads. Regions with a fold changeÂ &gt;1.5 (FCÂ &gt;1.5) were included for further analysis.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>Discrepancy between STARR-seq activity and luciferase reporter activity of selected regions.</title><p>(<bold>A</bold>) Overview of the murine <italic>Tbx3</italic> locus with ATAC_AVJ, EMERGE and STARR_SG4 data. Fragments selected for luciferase assay, selected either on STARR-seq activity or EMERGE/ATAC peaks are depicted below. (<bold>B</bold>) Correlation between luciferase reporter activity (fold change of reporter activity over activity of empty pGL2-SV40 vector; threshold FCÂ &gt;2) and STARR-seq (log2FC of SG4 over pcDNA control; threshold log2FCÂ &gt;0.58 (FCÂ &gt;1.5)) of selected fragments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig2-figsupp2-v1.tif"/></fig></fig-group><p>As AVCS-like cells are not available for large-scale and high-efficiency transfections, we transfected our STARR-seq libraries in COS-7 cells (a monkey kidney-derived fibroblast cell line), allowing us to assess the response of sequences within the libraries with high transfection efficiency specifically to the co-transfected transcription factors. Co-transfection of the libraries with pcDNA3.1 as control (m/hSTARR_ctrl) revealed multiple active sequences, indicative of REs capable of driving reporter gene expression in COS-7 cells (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). To find Smad/Gata and Wnt-responsive REs, we co-transfected the murine and human STARR libraries with Smad/Gata factors (m/hSTARR_SG4) or with Tcf-factors (m/hSTARR_Wnt), respectively. Regions with a log2 fold change ofÂ &gt;0.58 (fold changeÂ &gt;1.5) of SG4/Wnt-co-transfected activity over pcDNA-co-transfected activity were considered to activate transcription. Combined, we found 216 SG4- and 257 Wnt-responsive regions in the murine locus, and 206 SG4- and 190 Wnt-responsive regions in the human locus (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). The transcriptional potential of approximately 20% of the active mSTARR regions for both SG4- and Wnt-stimulation was functionally conserved between mouse and human, as the human homologues of these regions were active in the respective human STARR-seq libraries as well (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>). Duplicate transfections showed a strong correlation (<xref ref-type="fig" rid="fig2">Figure 2E,F</xref>). We performed transient transfection in COS-7 followed by luciferase assays with a subset of the identified regions to validate their regulatory potential. 84% of m/hSTARR regions (nÂ =Â 19) drove luciferase activityÂ &gt;2 fold relative to the vector containing only the core promoter, compared to 10% of randomly selected negative regions (nÂ =Â 10; m/hSTARR fold changeÂ &lt;1.5; p=0.0007 (two-sample t-test)) (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). These data confirm the positive signals (&gt;1.5 fold over control) in STARR-seq represent fragments with enhancer activity. Among the active regions are both human and murine homologues of Tbx3-eA and Tbx3-eB. pGL4-(Tbx2)<sub>4</sub> (tandem repeat of a 380 bp Tbx2 enhancer responding to Smad- and Gata4 factors) (<xref ref-type="bibr" rid="bib75">Stefanovic et al., 2014</xref>) and TOP/FOP (Wnt-signaling responsive TCF/LEF reporter assay) reporters showed strong luciferase activity upon stimulation with SG4- and Tcf-factors, respectively, validating that these factors activate SG4- and Tcf-responsive sequences upon transfection (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). A subset of the active regions from mSTARR_SG4 and from mSTARR_Wnt overlapped both each other and ATAC_AVCS regions (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), indicative of genomic regions both capable of activating reporter gene expression and being accessible in AVCS tissue. Similarly, a subset of hSTARR_SG4 and hSTARR_Wnt regions overlapped both each other and human EMERGE regions (<xref ref-type="fig" rid="fig2">Figure 2J</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 2B).</p><p>To further justify the legitimacy of the chosenÂ &gt;1.5 threshold for fold activity and to validate that the identified regions were indeed activated by either SG4- or Wnt-factors, we performed transcription factor motif enrichment analysis and found that the 216 mSTARR_SG4 sequences were enriched for binding motifs for Smad and Gata factors when compared to an equal number of randomly selected mSTARR_Wnt active sequences. Vice versa, binding motifs for Tcf factors are enriched in the 257 mSTARR_Wnt regions when compared to mSTARR_SG4 regions (<xref ref-type="fig" rid="fig2">Figure 2K</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 2A). These results indicate that 1) the regions we identified in the different libraries are activated by the respective cotransfected factors and 2) the threshold for regulatory activity ofÂ &gt;1.5 fold change used to filter and select these regions is justified. Combined, these results suggest that multiple regions within both the human and murine <italic>TBX3</italic> locus are accessible specifically in AVCS tissue and respond to Smad/Gata and Wnt-signaling to activate reporter gene expression, indicating they are potentially involved in <italic>TBX3</italic> regulation in the AVCS in vivo.</p></sec><sec id="s2-4"><title>Identification of variant REs within VR1 and VR2</title><p>For the identification of regulatory sequences throughout the human <italic>TBX3</italic> locus potentially involved in AVCS-specific gene expression, we used three approaches. First, we combined the human STARR-seq regions activated by either SG4- or Tcf-factors throughout the <italic>TBX3</italic> locus, resulting in 254 <italic>h</italic>STARR-REs (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Second, although epigenomic data from human AVCS tissue is scarce, we used cardiac-specific EMERGE enhancer prediction (<xref ref-type="bibr" rid="bib77">van Duijvenboden et al., 2016</xref>) and found 24 putative cardiac-specific <italic>h</italic>EMERGE REs within the <italic>TBX3</italic> locus (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Third, we translated and mapped the genomic sequences of the 67 <italic>m</italic>ATAC_AVJ regions and of the cardiac-specific mouse EMERGE predicted enhancers to the human genome, resulting in 62 mouse orthologous regions (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1A,B</xref>). Combined, this approach resulted in 296 candidate RE regions in the human <italic>TBX3</italic> locus, based on sequence activity (hSTARR), enhancer prediction based on various cardiac-specific epigenomic datasets (hEMERGE), and conservation with active and AVCS-specific accessible genomic regions from the mouse genome (mouse orthologous regions) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The previously identified human enhancer Tbx3-eA, driving AVCS expression and responding to Smad/Gata stimulation in vitro (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>), is marked by all three criteria, supporting the validity of our approach (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1C</xref>.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Approach for the identification of candidate REs potentially affected by GWAS variation.</title><p>(<bold>A</bold>) Active STARR regions within the human <italic>TBX3</italic> locus, responding to either SG4- or Tcf-factors. Log2 ratios of the fold change of SG4- or Tcf-stimulated respons to pcDNA is depicted. Blue bars represent active regions (fold changeÂ &gt;1.5) included for further analysis. (<bold>B</bold>) EMERGE enhancer prediction track (black) with selected enhancer candidates (red bars) included for further analysis. (<bold>C</bold>) Identification of candidate REs within the mouse <italic>Tbx3</italic> locus. Regions were selected based on ATAC_AVCS (top black track) and mouse EMERGE enhancer prediction (bottom black track). Selected regions (black bars) were translated to and plotted onto the human genome and included for further analysis. (<bold>D</bold>) Final RE candidate regions within the human <italic>TBX3</italic> based on the three criteria listed above. Blue bars: hSTARR regions; red bars: human EMERGE regions; black bars: mouse orthologous candidate regions translated to human genome. (<bold>E</bold>) Overlap of candidate regions from (<bold>D</bold>) within VR1 and VR2 with GWAS SNPs leads to final list of RE candidates potentially affected by GWAS variation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>STARR-seq of the murine <italic>Tbx3/Tbx5</italic> locus.</title><p>(<bold>A</bold>) Overview of the murine <italic>Tbx3/Tbx5</italic> locus with STARR-seq data tracks for mSTARR_SG4 (SG4-vs-ctrl) and mSTARR_Wnt (Wnt-vs-ctrl). The displayed tracks represent log2 fold changes of enrichment of SG4/Wnt-stimulated over the unstimulated control. (<bold>B</bold>) Zoom-in of VR1 and VR2 show overlap of mSTARR data tracks with tracks of ATAC-seq in embryonic AVJs, ChIP-seq for Gata4, Hand2 and H3K27ac, and EMERGE enhancer prediction. Black <italic>m</italic>RE bars below tracks depict final murine RE candidates selected based on signal in the different datasets. (<bold>C</bold>) Validated enhancer hTBX3-eA, previously shown to drive AVCS expression and to respond to SG4 stimulation in vitro (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>), is conserved between human and mice (Genomic Evolutionary Rate Profiling; GERP), shows STARR-seq activity for both SG4 and Wnt stimulation (hSG4/hWnt), is predicted by human EMERGE, and is accessible in murine Tbx3+ AVCS cardiomyocytes (ATAC_AVCS; mRE).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To assess whether these RE candidates harbor common variants associated with PR interval or QRS duration, we filtered for genomic location within VR1 or VR2 and found seven candidate variant REs within human VR1 and 13 candidate variant REs within VR2 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 5). To assess the regulatory potential of the candidate REs and to elucidate whether their activity is affected by genomic variation, we overlapped these REs with PR interval- or QRS duration-associated variants (p&gt;0.05) (<xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>), or variants in linkage disequilibrium (LD) with the most significantly associated variants within both regions (r<sup>2</sup>Â &gt;0.5; <xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 4). Combined, we found six candidate REs in VR1 and 6 candidate REs in VR2 harboring one or multiple variants (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><p>We measured luciferase reporter activity of the major and minor haplotype of these RE candidates and found that all RE candidates except for <italic>h</italic>RE5 drove basal luciferase reporter activity in both HL-1 and COS-7 cells (nÂ =Â 4; p&lt;0.05); <italic>h</italic>RE5 decreased reporter activity (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1A</xref>). Due to technical issues <italic>h</italic>RE13 was omitted from downstream experiments. We next measured regulatory activity of the risk and reference haplotypes for each RE. The risk allele of 4 REs (<italic>h</italic>RE5, <italic>h</italic>RE7, <italic>h</italic>RE8 and <italic>h</italic>RE18) increased basal reporter activity in HL-1 cells when compared to the reference allele, whereas the risk allele of <italic>h</italic>RE9, <italic>h</italic>RE11 and <italic>h</italic>RE15-16 decreased basal reporter activity in both HL-1 and COS-7 cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The risk allele of a subset of these regions also affected their SG4-/Wnt-induced activity (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1B</xref>). The SG4-dependent activity of <italic>h</italic>RE3 and <italic>h</italic>RE9 and the Wnt-dependent activity of <italic>h</italic>RE6 was increased by the risk allele, whereas the risk allele of <italic>h</italic>RE8, <italic>h</italic>RE15-16 and <italic>h</italic>RE18 decreased both SG4- and Wnt-dependent activity (<italic>h</italic>RE8, <italic>h</italic>RE18), or only Wnt-response (<italic>h</italic>RE15-16). Combined, these results show that multiple candidate REs within both VR1 and VR2 hold regulatory capacity in vitro, and that the activity of a subset of these regions (in both VR1 and VR2) is affected by the risk allele. We next analyzed whether potential TF binding motifs were disrupted or de novo created by the respective SNP in the variant region of the functionally affected REs to elucidate, thereby possibly explaining the differential effect of the risk allele on luciferase activity. None of the variants within the functionally affected fragments matched known TF binding motifs.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Identification of functional variants affecting RE candidate activity within human VR1 and VR2.</title><p>(<bold>A</bold>) Basal luciferase activity of the reference and alternative alleles for each RE candidate in HL-1 and COS-7 cells. Luciferase activities were normalized to the activity of the reference allele for each fragment, in both HL-1 and COS-7 cells. (<bold>B</bold>) Relative luciferase activity of the reference and alternative alleles for each RE candidate upon stimulation with Smad- and Gata4 factors (SG4) and Tcf+LiCl factors (Wnt) in COS-7 cells. SG4/Wnt activity of the alternative alleles were normalized to the respective activity of the reference allele for each RE candidate. Transfections were performed in duplicates and replicated twice. Error bars represent standard deviations. *: p&lt;0.05 (Studentâs t-test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Regulatory activity of RE candidates.</title><p>(<bold>A</bold>) Basal activity of reference alleles of RE candidates in HL1 (light grey bars) and COS7 cells (dark grey bars). Luciferase activity for each RE candidate is normalized to the activity of the empty pGL2-SV40 vector. (<bold>B</bold>) Luciferase activity of reference alleles of RE candidates upon stimulation with Smad/Gata- (SG4) and Tcf+LiCl- (Wnt) factors in COS7 cells. Luciferase activity of each RE candidate is normalized to the activity of each RE candidate upon co-transfection with pcDNA (control). Transfections were performed in duplicates and replicated twice. Error bars represent standard deviation. *: p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Genomic regions upstream of TBX3 drive AVCS expression</title><p>The murine region homologous to human VR2 is located within a region that we previously demonstrated to harbor sequences driving <italic>Tbx3</italic> expression in the ventral, right-sided and dorsal (primordial AV node) aspect of the AV canal (BAC 366H17-GFP; â82 kb to +78 kb relative to <italic>Tbx3</italic>; <xref ref-type="fig" rid="fig5">Figure 5</xref>; <xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>).Sequences within VR1 and VR2 are to a large extent evolutionary conserved between human and mouse, and VR2 harbors the AVC-specific RE (Tbx3-eA) that was functionally and structurally conserved between mouse and human (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>; <xref ref-type="fig" rid="fig5">Figure 5A,B</xref>).To elucidate the involvement of the distal variant region (VR1) in the regulation of cardiac <italic>Tbx3</italic> expression, we set out to probe this domain for its regulatory potential by modifying a BAC spanning â245 kb to â75 kb upstream of <italic>Tbx3</italic> (459M16-GFP; <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Although this BAC does not overlap VR2 and does not contain the previously identified RE (Tbx3-eA) driving AV node expression (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>), immunohistochemistry on sections of <italic>Tbx3</italic>-459M16-GFP E14.5 embryos revealed GFP reporter expression throughout the entire AVCS in a pattern resembling that of endogenous <italic>Tbx3</italic>, including the full AV canal and prospective AV node, AV bundle and BBs (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Furthermore, expression was found in the eye, ear, genital tubercle, limbs, and mammary glands (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). This expression pattern is similar to that of previously described BAC 89K7-GFP, which only partially overlaps 459M16 and contains <italic>Tbx3</italic> and both the synergistically acting REs Tbx3-eA and Tbx3-eB (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>; <xref ref-type="fig" rid="fig5">Figure 5D</xref>). These observations suggest that multiple physically separated regulatory regions independently drive AVCS expression (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>VR1 and VR2 are located within regulatory domains that redundantly drive AVCS expression.</title><p>(<bold>A</bold>) Zoom-in of the human <italic>TBX3</italic> locus depicting distal variant region VR1, harboring SNPs for both PR interval and QRS duration, and proximal variant region VR2, harboring SNPs for PR interval. Mouse conservation (green) depicts genomic sequences conserved in the mouse genome; GERP depicts evolutionary constraint of genomic regions. (<bold>B</bold>) Homologous murine region within the <italic>Tbx3</italic> locus corresponding to the region depicted in (<bold>A</bold>). Homologous regions of VR1 and VR2 are depicted. Dark grey lines depict the locations of GFP-modified BACs, harboring either only VR2 (143N21, 366H17), both VR1 and VR2 (89K7) or only VR1 (459M16). (<bold>C</bold>) Immunohistochemistry on section through E14.5 459M16-GFP heart shows GFP reporter gene expression throughout the entire AVCS (white arrows). The Hcn4<sup>+</sup> sinoatrial node does not express GFP. (<bold>D</bold>) Schematic overview of GFP-expression domains of BACs depicted in (<bold>B</bold>). The genomic region spanned by BACs 89K7 and 459M16, both harboring VR1, harbors regulatory elements driving expression throughout the complete AVCS including the atrioventricular bundle. The genomic region spanned by BACs 143N21 and 366H17 drive partial AVCS expression, not including left atrioventricular ring bundle and atrioventricular bundle expression. (<bold>E</bold>) Model of the topology of the <italic>Tbx3</italic> locus, depicting VR1 and VR2 both involved in regulation of <italic>Tbx3</italic> in the AV conduction system. Genomic sequences involved in the expression of <italic>Tbx3</italic> in the sinoatrial node are absent from these regions and likely reside more distally (grey dashed line). avb, atrioventricular bundle; avn, atrioventricular node; la, left atrium; lv, left ventricle; ra, right atrium; ravrb, right atrioventricular ring bundle; rv, right ventricle.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>BAC 459M16-GFP recapitulates AVCS expression.</title><p>(<bold>A</bold>) Fluorescence of GFP in whole E14.5 459M16-GFP embryo (left) and isolated heart (right). Expression is seen in among others the whisker placodes, limb buds, mammary glands and developing retina. Within the heart, GFP expression is observed in the atrioventricular canal, the atrioventricular bundle and the bundle branches. (<bold>B</bold>) Table listing regions where Tbx3 is endogenously expressed and where GFP expression in 459M16-GFP E14.5 embryos is (+) or is not (-) observed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig5-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Analysis of the function of VR1 and VR2 in vivo</title><p>To analyze the involvement of VR1 in endogenous regulation of gene expression and heart function, we used TALEN-mediated genome editing to delete the 69 kb homologous region (â245 kb to â176 kb relative to <italic>Tbx3</italic>) from the murine genome (<italic>Tbx3<sup>âVR1</sup></italic>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). We validated the deletion by PCR and Sanger sequencing (<xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1A,B</xref>). <italic>Tbx3<sup>+/+</sup>, Tbx3<sup>ÎVR1/+</sup></italic> and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> mice were born according to Mendelian ratios (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). We measured expression levels in microdissected AV junctions (containing the AV node and AV bundle) of E13.5 <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> hearts and found that expression of <italic>Tbx3</italic> or neighboring <italic>Med13l</italic> and <italic>Tbx5</italic> was not affected (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, not shown for <italic>Med13l</italic> and <italic>Tbx5</italic>). To elucidate whether deletion of VR1 affects AVCS function postnatally, we performed surface ECGs on adult <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> mice and found no difference in PR interval or QRS duration between genotypes (<italic>Tbx3<sup>+/+</sup></italic> nÂ =Â 10, <italic>Tbx3<sup>ÎVR1/+</sup></italic> nÂ =Â 12, <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> nÂ =Â 9; <xref ref-type="fig" rid="fig6s2">Figure 6âfigure supplement 2AâC</xref>). To exclude a possible rescue effect of the sympathetic nervous system on AVCS function in the absence of VR1, we measured conduction parameters by ex vivo ECG recordings on Langendorff perfused hearts and again found no difference between <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> hearts (<xref ref-type="fig" rid="fig6s2">Figure 6âfigure supplement 2D,E</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Genomic deletion of VR1 and VR2 in vivo.</title><p>(<bold>A</bold>) Mouse genomic regions targeted by TALEN- (VR1) or CRISPR-Cas9- (VR2) mediated genome editing. (<bold>B</bold>) Genotype ratios of âVR1 mutant and wildtype born pups, depicted as percentage of total number of pups. (<bold>C</bold>) Relative expression levels of <italic>Tbx3</italic> in <italic>Tbx3<sup>+/+</sup></italic> (nÂ =Â 8) and <italic>Tbx3<sup>âVR1/âVR1</sup></italic> (nÂ =Â 12) microdissected E13.5 AV junctions. Expression levels are normalized to the expression of <italic>Tbx2.</italic> (<bold>D</bold>) Genotype ratios of âVR2 mutant and wildtype born pups, depicted as percentage of total number of pups, revealing the number of <italic>Tbx3<sup>âVR2/âVR2</sup></italic> pups is lower than expected according to Mendelian ratios (*: p&lt;0.01). (<bold>E</bold>) Relative expression levels of <italic>Tbx3</italic> in <italic>Tbx3<sup>+/+</sup></italic> (nÂ =Â 8) and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> (nÂ =Â 9) microdissected E13.5 AV junctions, revealing increased expression of <italic>Tbx3</italic> in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mutants (p&lt;0.05). Expression levels are normalized to the expression of <italic>Tbx2.</italic> (<bold>F</bold>) Expression levels of target genes of <italic>Tbx3</italic> in microdissected E13.5 AV junctions, expression levels of neighboring genes in microdissected E13.5 AV junctions, and expression levels of <italic>Tbx3</italic> in other tissues in which Tbx3 is expressed, in <italic>Tbx3<sup>+/+</sup></italic> (nÂ =Â 8) and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> (nÂ =Â 9) E13.5 embryos. Expression levels were normalized to the expression of <italic>Tbx2</italic> (AV junctions), <italic>Isl1</italic> (SAN) or <italic>Hprt</italic> (lung, limb, liver). *:p&lt;0.05. (<bold>G</bold>) In-situ hybridization on sections of <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> E13.5 hearts shows expression of Tbx3 in the cardiac conduction system, including the sinoatrial node, atrioventricular canal, atrioventricular bundle and bundle branches. The expression pattern is not affected in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts. (<bold>H,I</bold>) PR interval (<bold>H</bold>) and QRS duration (<bold>I</bold>) in <italic>Tbx3<sup>+/+</sup></italic> (WT; nÂ =Â 8) and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> (hom; nÂ =Â 8) mice measured by surface ECG on male mice (2â4 months old). *:p&lt;0.05. avb, atrioventricular bundle; avc, atrioventricular canal; cgn, cardiac ganglia; la, left atrium; lsh, left sinus horn; lu, lung; lv, left ventricle; ra, right atrium; rv, right ventricle; san, sinoatrial node.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 1.</label><caption><title>Validation of genomic deletion of VR1 and VR2.</title><p>(<bold>A</bold>) UCSC browser view of the murine <italic>Tbx3</italic> locus with the location of VR1 and VR2 depicted. Numbered arrows depict primers used for genotyping. Grey lettered arrows depict the location of regions within VR1/VR2 to test for proper deletion in <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> and <italic>Tbx3<sup>ÎVR2/ÎVR2</sup></italic> as shown in (<bold>B</bold>). (<bold>B</bold>) Genotyping by PCR (left) and Sanger sequencing (right) show regions A, B and C (VR1) and D, E and F (VR2) are absent in <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> and <italic>Tbx3<sup>ÎVR2/ÎVR2</sup></italic> mice. Sanger sequencing on the PCR product of primer pairs 1â2 and 3â4 flanking VR1 and VR2 reveal exclusion of these regions from the genome.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 2.</label><caption><title>Characterization of <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> and <italic>Tbx3<sup>ÎVR2/ÎVR2</sup></italic> mice.</title><p>(<bold>A,B</bold>) PR interval and QRS duration in <italic>Tbx3<sup>+/+</sup></italic> (WT; nÂ =Â 9)<italic>, Tbx3<sup>ÎVR1/+</sup></italic> (het; nÂ =Â 12) and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> (hom; nÂ =Â 10) mice measured by surface ECG. No significant difference between the different genotypes was observed. (<bold>C</bold>) Average values for PR interval, QRS duration and RR intervals for <italic>Tbx3<sup>+/+</sup></italic> (WT)<italic>, Tbx3</italic><bold><italic><sup>ÎVR1/+</sup></italic></bold> (het) and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> (hom) mice as measured by surface ECG. Values depict averageÂ Â±Â standard error of the mean. (<bold>D,E</bold>) PR interval and QRS duration in <italic>Tbx3<sup>+/+</sup></italic> (WT; nÂ =Â 6) and <italic>Tbx3<sup>ÎVR1/ÎVR1</sup></italic> (hom; nÂ =Â 6) Langendorff perfused hearts (ex vivo ECG). No significant difference between genotypes was observed. (<bold>F</bold>) Average values for PR interval, QRS duration and RR intervals for <italic>Tbx3<sup>+/+</sup></italic> (WT) and <italic>Tbx3<sup>ÎVR2/ÎVR2</sup></italic> (hom) mice as measured by surface ECG. Values depict averageÂ Â±Â standard error of the mean. (<bold>G,H</bold>) PR interval and QRS duration in <italic>Tbx3<sup>+/+</sup></italic> (WT; nÂ =Â 6) and <italic>Tbx3<sup>ÎVR2/ÎVR2</sup></italic> (hom; nÂ =Â 6) Langendorff perfused hearts (ex vivo ECG). No significant difference between genotypes was observed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56697-fig6-figsupp2-v1.tif"/></fig></fig-group><p>To assess the endogenous role of VR2 in the regulation of gene expression and AVCS function, we used CRISPR/Cas9-mediated genome editing to delete the 51 kb homologous region (â54 kb to â3 kb relative to <italic>Tbx3</italic>) from the murine genome (<italic>Tbx3<sup>âVR2</sup></italic>). Again, we validated the deletion by PCR and Sanger sequencing (<xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1A,C</xref>). At E13.5, the observed distribution of <italic>Tbx3<sup>+/+</sup>, Tbx3<sup>âVR2/+</sup></italic> and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> embryos followed Mendelian ratios (data not shown). Postnatally, however, the observed number of <italic>Tbx3<sup>âVR2/âVR2</sup></italic> pups was approximately half of the expected number (p=0.004, Ï2 test; <xref ref-type="fig" rid="fig6">Figure 6D</xref>). We analyzed expression levels of <italic>Tbx3</italic> in microdissected AV junctions of E13.5 hearts and found an approximately 2.5-fold increase in expression in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts compared to <italic>Tbx3<sup>+/+</sup></italic> littermates (p=2*10<sup>â11</sup>; nÂ =Â 8 and nÂ =Â 9, respectively; <xref ref-type="fig" rid="fig6">Figure 6E</xref>), respectively. <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts showed increased expression of <italic>Hcn4</italic> (p=0.04) and <italic>Cacna1g</italic> (p=0.004), ion channel-encoding genes involved in AVCS function, and decreased expression of <italic>Scn5a</italic> (p=0.02), the cardiac sodium channel Nav1.5-encoding gene involved in conduction, compared to hearts of wildtype littermates (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Expression levels of <italic>Gja5</italic> and <italic>Gja1,</italic> target genes of <italic>Tbx3</italic> in the AVCS and encoding the fast conducting gap junction proteins Cx40 and Cx43, respectively, were not affected (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). To assess whether deletion of VR2 affects the expression of genes flanking <italic>Tbx3,</italic> we measured expression levels of <italic>Tbx5</italic>, <italic>Rbm19</italic> and <italic>Med13l</italic> and found that expression of these genes was unchanged (<xref ref-type="fig" rid="fig6">Figure 6F</xref>), suggesting VR2 only regulates <italic>Tbx3</italic> in the AVCS. <italic>Tbx3</italic> is also involved in the development of other tissues including the limbs, liver and lungs (<xref ref-type="bibr" rid="bib22">Davenport et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">LÃ¼dtke et al., 2009</xref>; <xref ref-type="bibr" rid="bib46">LÃ¼dtke et al., 2013</xref>). As the observed number of <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mice after birth was lower than expected, we asked whether <italic>Tbx3</italic> expression in these tissues is affected upon deletion of VR2, thereby potentially causing lethality. We measured <italic>Tbx3</italic> expression levels in sinoatrial nodes (SANs), forelimbs, liver and lungs of E13.5 embryos, and found increased expression only in the SAN (p=0.013). Expression in other tissues was not affected (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). We next asked whether the upregulation of <italic>Tbx3</italic> in the embryonic AVCS is caused by increased expression in cells within its expression domain or by expansion of its expression domain in the heart. We performed in situ hybridization on E13.5 <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts and observed no difference in expression pattern for <italic>Tbx3</italic> between <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts (<xref ref-type="fig" rid="fig6">Figure 6G</xref>).</p><p>To assess the in vivo effects of deletion of VR2 on PR interval and QRS duration, we measured surface ECGs in <italic>Tbx3<sup>+/+</sup></italic> and <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mice (nÂ =Â 8 and nÂ =Â 8, respectively). <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mice showed shortened PR intervals compared to <italic>Tbx3<sup>+/+</sup></italic> mice (30.4 ms and 35.3 ms, respectively; p=0.025; <xref ref-type="fig" rid="fig6">Figure 6H</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6âfigure supplement 2F</xref>). The QRS duration in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mice was increased compared to wildtypes (15.1 ms and 11.7 ms, respectively; p=0.004; <xref ref-type="fig" rid="fig6">Figure 6I</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6âfigure supplement 2F</xref>). Recordings of ex vivo ECGs on these hearts under Langendorff perfusion revealed a similar effect on PR interval and QRS duration, suggesting the autonomic nervous system is not involved in changed parameters upon deletion of VR2 (<xref ref-type="fig" rid="fig6s2">Figure 6âfigure supplement 2G,H</xref>).</p><p>Taken together, these results show that deletion of VR1 in mice does not affect expression levels or AVCS function. Deletion of VR2 affects <italic>Tbx3</italic> expression in the AVCS and causes misregulation of target genes and affected conduction parameters.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Deciphering the mechanisms underlying gene regulation and the effects of trait-associated variation on these mechanisms is challenging for tissue types like the AVCS, which is small, heterogeneous and poorly available, and for which relevant model cells for functional and (epi)genomic experiments do not yet exist. Here, we functionally characterized two variant regions in the gene desert upstream of <italic>TBX3</italic> that have been associated with PR interval and QRS duration, parameters for cardiac conduction, in the human population. Both regions are located within genomic domains that recapitulate AVCS expression in vivo. They harbor multiple active regulatory elements as determined by STARR-seq and analysis of epigenetic data, the activity of a subset of which was found to be affected by the risk haplotype. Deletion of the orthologue of the distal region from the mouse genome did not affect <italic>Tbx3</italic> expression or AVCS function. Deletion of the proximal region increased <italic>Tbx3</italic> expression in the AVCS and affected both PR interval and QRS duration in vivo.</p><p>A large number of PR interval and QRS duration-associated variants has been identified within loci close to genes important for cardiac conduction system development and function (<xref ref-type="bibr" rid="bib61">Pfeufer et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Sotoodehnia et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>; <xref ref-type="bibr" rid="bib83">Verweij et al., 2014</xref>). Assigning function to these associations has been proven challenging. The vast majority of GWAS variation is located in non-coding genomic regions and therefore potentially affects the function of <italic>cis-</italic>REs, substantially impacting gene regulation and contributing to disease susceptibility (<xref ref-type="bibr" rid="bib51">Maurano et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Schaub et al., 2012</xref>). The identification of REs driving expression of genes active in the AVCS is hampered by the fact that the AVCS comprises only a small proportion of the heart. Consequently, the isolation of AVCS tissue for experimental procedures is challenging. eQTL analysis of associated variants is limited by the low number of available genotyped human AVCS samples, and AVCS-like cell lines for downstream functional testing of regulatory mechanisms are lacking. Using genome-wide murine AVCS-specific ATAC-seq and murine and human locus-wide functional enhancer screening using STARR-seq, we aimed to circumvent these issues and generate a means to identify REs potentially affected by GWAS variation.</p><p>GWAS typically identifies common variants, relatively frequently present in the human genome, and their effect size on the respective traits is usually small (<xref ref-type="bibr" rid="bib49">Manolio et al., 2009</xref>; <xref ref-type="bibr" rid="bib52">McCarthy et al., 2008</xref>). Haploinsufficiency of <italic>TBX3</italic>, <italic>TBX5</italic> and other transcription factor-encoding genes causes congenital defects (<xref ref-type="bibr" rid="bib9">Bamshad et al., 1997</xref>; <xref ref-type="bibr" rid="bib10">Basson et al., 1999</xref>; <xref ref-type="bibr" rid="bib72">Seidman and Seidman, 2002</xref>) and is therefore not well tolerated, implying that even the modest effects of common variants on expression of such genes may have a relatively large effect on phenotypes. Furthermore, genes encoding developmental transcription factors are frequently under transcriptional control of multiple redundant REs (<xref ref-type="bibr" rid="bib16">CannavÃ² et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Moorthy et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Osterwalder et al., 2018</xref>). The cardiac and limb expression of <italic>Tbx3</italic> involves multiple redundant or synergistically acting REs, which was previously shown by modified BAC and reporter transgenics (<xref ref-type="bibr" rid="bib59">Osterwalder et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>). Our current findings further substantiate regulatory redundancy in vivo. Two different BACs harbor the regulatory information for reporter gene expression in the AVCS and other tissues expressing <italic>Tbx3</italic>, whereas deletion of VR1 did not affect gene expression or AVCS function (<xref ref-type="bibr" rid="bib59">Osterwalder et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>). Combining this RE redundancy with the small effect size of associated variants, efforts to pinpoint individual causal variants in vivo or in modified (human) pluripotent stem cell-derived cardiac cell types will be challenging and with the currently available tools probably futile. Indeed, associations for many disease risk loci arise from multiple variants in LD that affect clusters of enhancers targeting the same gene (<xref ref-type="bibr" rid="bib21">Corradin and Scacheri, 2014</xref>). Therefore, we set out to assess the effect of deletion of the entire variant regions within the <italic>TBX3</italic> locus rather than assessing the effect of individual SNPs, and found that the two <italic>TBX3</italic> risk loci harbor multiple active REs whose activity is affected by their respective risk alleles. Common genomic variation within these regions therefore probably affects the function of multiple redundant REs, rather than individual elements, that together orchestrate the complex regulation of <italic>Tbx3</italic> expression in the AVCS.</p><p>Despite the presence of four active REs within VR1, the activity of which is affected by PR and QRS duration associated variation, deletion of the VR1 orthologue from the murine genome did not lead to affected gene expression or AVCS function. Disease-causing non-coding variants in the human genome can affect RE activity and thereby gene expression by altering transcription factor binding (<xref ref-type="bibr" rid="bib24">Deplancke et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Maurano et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Schaub et al., 2012</xref>), resulting in GWAS association. Genomic deletion of the entire VR1 removes the potentially affected REs from the genome and disrupts the topology of the locus, which could be functionally buffered by redundancy within the locus (<xref ref-type="bibr" rid="bib16">CannavÃ² et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Long et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Osterwalder et al., 2018</xref>). Such redundancy is possibly not deployed in the case of only a variable nucleotide in an otherwise unaffected regulatory sequence (or genomic topology), providing a possible explanation for the absence of effect we observed in <italic>Tbx3<sup>âVR1/âVR1</sup></italic> mice (<xref ref-type="bibr" rid="bib16">CannavÃ² et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Long et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Osterwalder et al., 2018</xref>).</p><p>Deletion of VR2 from the murine genome results in increased expression of <italic>Tbx3,</italic> and affected AVCS function. Regulation of the precise spatiotemporal activation of gene expression is orchestrated by various types of regulatory DNA elements including promoters, enhancers, silencers, insulators and other types of elements involved in conformation (<xref ref-type="bibr" rid="bib32">Heintzman et al., 2009</xref>; <xref ref-type="bibr" rid="bib44">Long et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Maston et al., 2006</xref>). As we have previously identified an RE (Tbx3-eA) that activates gene expression in the AVCS (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>) that is located within VR2 (<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>), the increased expression of <italic>Tbx3</italic> observed in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> hearts could be caused by a disruption of the fine balance between activating and repressive REs within VR2 that orchestrate the modulation of <italic>Tbx3</italic> regulation. Indeed, in the adult heart multiple regions within VR2 are marked by H3K27me3 (data not shown), a histone mark associated with transcriptional repression (<xref ref-type="bibr" rid="bib29">Gilsbach et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Mozzetta et al., 2015</xref>), suggesting VR2 potentially harbors multiple silencer elements.</p><p>The role of Tbx3 in conduction system function and development has been well demonstrated (<xref ref-type="bibr" rid="bib7">Bakker et al., 2008</xref>; <xref ref-type="bibr" rid="bib26">Frank et al., 2011</xref>; <xref ref-type="bibr" rid="bib35">Hoogaars et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Horsthuis et al., 2009</xref>). Tbx3 has a large number of target genes enriched for ion handling protein-encoding genes (<xref ref-type="bibr" rid="bib8">Bakker et al., 2012</xref>; <xref ref-type="bibr" rid="bib26">Frank et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Horsthuis et al., 2009</xref>). As such, hundreds of genes that potentially influence the electrophysiological properties of the AVCS are likely to be deregulated in <italic>Tbx3<sup>âVR2/âVR2</sup>.</italic> Not only <italic>Tbx3</italic> insufficiency (<xref ref-type="bibr" rid="bib7">Bakker et al., 2008</xref>; <xref ref-type="bibr" rid="bib26">Frank et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Horsthuis et al., 2009</xref>) but also over-expression (this study, <xref ref-type="bibr" rid="bib15">Burnicka-Turek et al., 2020</xref>) can be detrimental, suggesting proper AVCS function depends on strictly balanced Tbx3 levels. The balance between Tbx3 (imposing a nodal gene program) and Tbx5 (imposing a fast-conductive gene program) was found to be important in the function and gene regulation of the VCS (i.e. AV bundle and branches) (<xref ref-type="bibr" rid="bib15">Burnicka-Turek et al., 2020</xref>). This balance model would predict conduction slowing when Tbx3 levels are increased. However, we observed shortened PR intervals indicative of faster AVCS conduction in <italic>Tbx3<sup>âVR2/âVR2</sup></italic> mice (which have 2â3 fold increased <italic>Tbx3</italic> expression levels in AVCS), while <italic>Tbx5</italic> was not deregulated. This suggests that the Tbx3/Tbx5 balance model does not hold for the AV node. Several other transcription factors have been implicated in AVCS gene regulation, which together with Tbx3 and Tbx5 form a complex gene regulatory network that has not yet been fully elucidated (<xref ref-type="bibr" rid="bib79">van Eif et al., 2019</xref>). Further studies are required to unravel the mechanisms through which <italic>Tbx3</italic> dose influences the AVCS gene regulatory network and PR interval or QRS duration.</p><p>A major limitation of massive parallel reporter assays like STARR-seq is that DNA fragments are tested for regulatory potential episomally and out of genomic context (<xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref>), lacking the intricate relationship between DNA, histones and long range chromatin interactions (<xref ref-type="bibr" rid="bib27">Gallagher and Chen-Plotkin, 2018</xref>; <xref ref-type="bibr" rid="bib38">Inoue and Ahituv, 2015</xref>). Intrinsic sequence activity or transcription factor binding to motifs within regions endogenously repressed or residing in closed chromatin might activate reporter gene expression when tested in episomal assays. This potentially yields multiple false positive sequences, thatÂ is transcriptionally active sequences not relevant for endogenous gene regulation (<xref ref-type="bibr" rid="bib39">Inukai et al., 2017</xref>). Furthermore, we used the reporter vector described in <xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref> to generate our libraries. A recent study from the same group showed that the bacterial plasmid origin-of-replication within this vector acts as a conflicting core-promoter, thereby causing confounding false-positives and ânegatives (<xref ref-type="bibr" rid="bib56">Muerdter et al., 2018</xref>). In addition, the relatively high basal activity of the super core promoter (SCP1) in this vector potentially decreases the fold-change of signal to input (<xref ref-type="bibr" rid="bib56">Muerdter et al., 2018</xref>). As enhancer activity often depends on its ability to interact with the proper promoter (<xref ref-type="bibr" rid="bib4">Arnold et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Zabidi et al., 2015</xref>), testing our libraries with the endogenous <italic>Tbx3</italic> promoter could yield more relevant RE candidates. The weak overlap of STARR-seq regions with EMERGE and AVCS-ATAC-seq regions illustrates that a subset of the STARR-seq-identified active regions might not be transcriptionally relevant for <italic>Tbx3</italic> expression in vivo. Indeed, the correlation is low between luciferase reporter activity and STARR-seq activity of candidate sequences from the murine genome selected based on either strong epigenomic hallmarks (EMERGE/ChIP-seq/ATAC-seq; high luciferase-/low STARR-seq activity) or strong STARR-seq signal (mSTARR_SG4; high STARR-seq-/low luciferase activity) (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>). Nevertheless, given the scarcity of alternative epigenomic datasets derived from human AVCS tissue, STARR-seq on the human <italic>TBX3</italic> locus provides a useful albeit somewhat more supportive tool to identify REs.</p><p>The lack of readily available AVCS cell lines prompted us to transfect our STARR-seq libraries in COS-7 cells, a monkey kidney-derived fibroblast cell line. Although seemingly irrelevant for assessing regulatory activity of potential AVCS-involved REs, the high transfection efficiency of COS-7 cells allowed us to screen multiple libraries on a large scale and acquire sufficient coverage. The inactivity of a cardiac-specific gene program in COS-7 cells furthermore allowed us to specifically assess the response of genomic fragments to the cotransfected SG4- and Tcf-factors. Our observation that binding motifs for these factors are specifically enriched in AVCS cardiomyocytes, indicated these factors may be involved in regulation of the AVCS gene program. Motif enrichment in AVCS-specific accessible regions was performed by matching AVCS-specific accessible regions to motifs present in the HOMER database. Such databases have their limitations, as they are incomplete and possibly inaccurate as they derive their input from experimental procedures that are condition- and cell type-dependent. Nevertheless, the observed enrichment supported previous studies implicating Bmp-signalling (Smads), Gata4/6 and Wnt-signalling (Tcf) in AVCS patterning (<xref ref-type="bibr" rid="bib75">Stefanovic et al., 2014</xref>;Â <xref ref-type="bibr" rid="bib28">Gillers et al., 2015</xref>).</p><p>Several of the tested risk alleles (e.g. hRE8, hRE9, hRE18) showed a discordant direction of effect between basal activity in COS-7/HL-1 and SG4-/Wnt-stimulated activity. This observation suggests that potentially multiple factors act on these variant REs, with SG4- or Tcf factors counteracting the effect of regulatory networks active in COS-7 or HL-1 cells. Although we could not identify specific TF binding motifs affected by the respective SNPs in these REs, studying TF occupancy in more detail specifically in AVCS cells could elaborate on the precise mechanisms through which these variant REs act. By focusing on SG4- and Wnt-responsive REs, we potentially overlook a proportion of relevant sequences involved in the regulation of <italic>Tbx3</italic> expression, as multiple other factors are involved in AVCS development (<xref ref-type="bibr" rid="bib11">Bhattacharyya and Munshi, 2020</xref>; <xref ref-type="bibr" rid="bib60">Park and Fishman, 2017</xref>; <xref ref-type="bibr" rid="bib79">van Eif et al., 2019</xref>). Recent and ongoing advantages in the generation of (sinoatrial/atrioventricular) nodal-like cells derived from human pluripotent stem cells (<xref ref-type="bibr" rid="bib12">Birket et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Jung et al., 2014</xref>; <xref ref-type="bibr" rid="bib62">Protze et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Rimmbach et al., 2015</xref>) will provide a promising tool to study the regulation of genes involved in AVCS development and the function of candidate REs in a considerably more relevant cell type.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Cell line (<italic>Chlorocebus aethiops</italic>)</td><td>COS-7</td><td>ATCC</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0224">CVCL_0224</ext-link></td><td>Fibroblast cell line</td></tr><tr><td>Cell line (<italic>Mus musculus</italic>)</td><td>HL-1</td><td>William C. Claycomb (<xref ref-type="bibr" rid="bib20">Claycomb et al., 1998</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0303">CVCL_0303</ext-link></td><td>Cardiomyocyte cell line</td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td><italic>Tbx3<sup>âVR1/+;</sup> Tbx3<sup>âVR1/âVR1</sup></italic></td><td>This paper</td><td/><td>See Materials and methods, section âTALEN/CRISPR/Cas9-mediated genome editing of <break/>VR1 and VR2â</td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td><italic>Tbx3<sup>âVR2/+;</sup> Tbx3<sup>âVR2/âVR2</sup></italic></td><td>This paper</td><td/><td>See Materials and methods, section âTALEN/CRISPR/Cas9-mediated genome editing of VR1 and VR2â</td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td><italic>Tbx<sup>459M16-GFP/+</sup></italic></td><td>This paper</td><td/><td>See Materials and methods, section âBAC modification and immunohistochemistryâ</td></tr><tr><td>Recombinant DNA reagent</td><td>pSTARR-seq_human</td><td><xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref></td><td>Addgene; <break/>Plasmid #71509</td><td/></tr><tr><td>Commercial assay or kit</td><td>Nextera DNA library <break/>prep kit</td><td>Illumina</td><td>FC-121â1030</td><td/></tr><tr><td>Commercial assay or kit</td><td>NEBNext DNA Library Preparation Kit</td><td>New England Biolabs</td><td>NEB E6000S</td><td/></tr><tr><td>Commercial assay or kit</td><td>NEBNext Multiplex <break/>Oligos for Illumina</td><td>New England Biolabs</td><td>NEB E7335S</td><td/></tr><tr><td>Software, algorithm</td><td>EMERGE</td><td><xref ref-type="bibr" rid="bib77">van Duijvenboden et al., 2016</xref></td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>SNP plotting and human Hi-C analysis</title><p>Genome-wide significant SNPs associated with PR interval and QRS duration were extracted from <xref ref-type="bibr" rid="bib76">van der Harst et al., 2016</xref> and <xref ref-type="bibr" rid="bib81">van Setten et al., 2018</xref>. Within genomic loci marked by genome-wide significant SNPs (p&lt;5*10<sup>â8</sup>), SNPs with a p-value&lt;0.05 were included according to the relevance of sub-threshold SNPs described in ref (<xref ref-type="bibr" rid="bib85">Wang et al., 2016</xref>). We also included common variants in high linkage disequilibrium (LD; r<sup>2</sup>Â &gt;0.5) with the top SNPs for both variant regions in our analysis (<xref ref-type="bibr" rid="bib48">Machiela and Chanock, 2015</xref>). SNPs were plotted on the human genome (hg19) using the UCSC Genome Browser (<xref ref-type="bibr" rid="bib41">Kent et al., 2002</xref>). Hi-C data of the human <italic>TBX3</italic> locus and resulting TAD boundaries were obtained from GM12878 human lymphoblastoid cells (<xref ref-type="bibr" rid="bib66">Rao et al., 2014</xref>).</p></sec><sec id="s4-2"><title>ATAC-seq on Tbx3+ AVCS cardiomyocytes</title><p>ATAC-seq on FACS-purified E12.5-E14.5 <italic>Tbx3<sup>Venus/+</sup></italic> AVJs (<xref ref-type="bibr" rid="bib79">van Eif et al., 2019</xref>) was performed and analyzed as described in <xref ref-type="bibr" rid="bib14">Buenrostro et al., 2013</xref>. In short, <italic>Tbx3</italic><sup>Venus/+</sup> hearts were dissected from embryonic day (E) 12.5-E14.5 embryos and enriched for AV conduction system tissues by microdissection. Single-cell suspensions were obtained using 0.05% Trypsin/EDTA (ThermoFisher Scientific, 25300â054). Cells were sorted on a FacsAria flow cytometer (BD biosciences) and gated to exclude debris and cell clumps, and sorted for Venus<sup>+</sup> cells. Approximately 75.000 Venus<sup>+</sup> cells were collected and used as input for ATAC-sequencing, which was performed as previously described (<xref ref-type="bibr" rid="bib14">Buenrostro et al., 2013</xref>). The library was sequenced (paired-end 125 bp) and data was collected on a HiSeq2500. ATAC-seq data is deposited in the GEO database under accession number GSE121464.</p></sec><sec id="s4-3"><title>STARR-seq library preparation</title><p>STARR-seq was performed as described previously (<xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref>). In short, BACs spanning the entire human and murine <italic>TBX3</italic> locus were used to generate human and murine STARR-seq libraries. BACs were equimolarly pooled, approximately 15 Âµg of pooled BAC DNA was sheared by sonication (Amp 20%, 2 Ã 15 s) and fragments of approximately 500â1000 bp were selected by gel extraction followed by cleanup using the Qiaquick Gel extraction kit (Qiagen; 28704). 1.5 Âµg of size-selected DNA fragments was used as input for library preparation using the NEBNext DNA Library Preparation Kit (NEB; E6000S) and NEBNext Multiplex Oligos for Illumina (NEB E7335S) according to manufacturerâs protocol. Recombination of adapter-ligated DNA fragments, transformation and library DNA isolation was performed as described (<xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref>).</p></sec><sec id="s4-4"><title>STARR-seq transfection</title><p>15*10<sup>6</sup> COS-7 cells were cultured in DMEM (ThermoFisher Scientific; 31966â021) supplemented with 10% FBS (ThermoFisher Scientific; 10270â106) and 1% Pen/Strep (ThermoFischer Scientific; 15070â063). Cells were transfected with 150 Âµg library DNA and 75 Âµg of pcDNA (control), SG4 (15 Âµg Smad1, 15 Âµg Smad4, 30 Âµg Alk3 and 15 Âµg Gata4 expression vectors) or Wnt (15 Âµg Tcf4 expression vector, 60 Âµg pcDNA, and 0.4M LiCl) using Polyethylenimine 25 kDa (PEI; Sigma-Aldrich; 408727) in a ratio of 1:3 (DNA:PEI). Medium was refreshed 6 hr after transfection. 48 hr after transfection, total RNA was isolated using the Qiagen RNeasy maxi prep kit (Qiagen; 75162). polyA+ RNA was isolated using Dynabeads Oligo-dT<sub>25</sub> (ThermoFisher Scientific; 61002) and treated with Ambion turboDNase (ThermoFisher Scientifc; AM2238) for 30 min at a maximum concentration of 150 ng/Âµl. RNA was purified using the Qiagen RNeasy MinElute kit (Qiagen; 74204). First-strand cDNA synthesis and library preparation was performed as describedÂ (<xref ref-type="bibr" rid="bib3">Arnold et al., 2013</xref>). Library quality and concentration were assessed by Bioanalyzer (Agilent) and KAPA Library Quantification Kit (KAPA Biosystems; KK4824). Libraries were pooled equimolarly and sequenced on an Illumina MiSeq (PE150).</p></sec><sec id="s4-5"><title>STARR-seq data analysis</title><p>Paired-end sequence reads were mapped to mm9 (mSTARR) or hg19 (hSTARR) using BWA (<xref ref-type="bibr" rid="bib43">Li and Durbin, 2009</xref>). For visualization purposes, bam files were converted to bigwig files using bamCoverage (<xref ref-type="bibr" rid="bib64">RamÃ­rez et al., 2016</xref>) and visualized using the UCSC genome browser (<xref ref-type="bibr" rid="bib41">Kent et al., 2002</xref>). We compared bam files of m/hSTARR_SG4/Wnt to m/hSTARR_control using bamCompare (<xref ref-type="bibr" rid="bib64">RamÃ­rez et al., 2016</xref>) with bin sizes of 50 bases to compute the log2 of the number of reads ratio. Bins were filtered to exclude regions with a read countÂ &lt;75. Flanking bins were merged using mergeBED (overlaps on either strand; maximum distance between features: 0) (<xref ref-type="bibr" rid="bib63">Quinlan and Hall, 2010</xref>). Merged bins with a log2 fold change ofÂ &gt;0.585 (fold changeÂ &gt;1.5) were included for further analysis. For overlap analysis, bed files were intersected using BEDTools (<xref ref-type="bibr" rid="bib63">Quinlan and Hall, 2010</xref>) with a minimum interval overlap of 50 bp.</p></sec><sec id="s4-6"><title>EMERGE enhancer selection</title><p>Putative mouse cardiac enhancers were predicted by EMERGE (<xref ref-type="bibr" rid="bib77">van Duijvenboden et al., 2016</xref>) using a total of 116 selected functional genomic datasets. These included ChIP-seq data of enhancer-associated histone modification marks and transcription factor binding sites, and chromatin accessibility data as assessed by DNAseI-hypersensitivity and ATAC-seq, derived predominantly from cardiac cells. By assigning weight to all selected datasets through a logistic regression modeling approach (described in <xref ref-type="bibr" rid="bib77">van Duijvenboden et al., 2016</xref>) using validated heart enhancers as training set, a genome-wide cardiac enhancer prediction track was generated. The same exercise was performed for the human genome, using a total of 70 selected functional genomic datasets. An overview of the datasets used of mouse and human EMERGE enhancer prediction is provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Tables 10, 11.</p></sec><sec id="s4-7"><title>ATAC-seq and H/mSTARR regions motif analysis</title><p>The ATAC-seq dataset on FACS-purified E12.5-E14.5 <italic>Tbx3<sup>Venus/+</sup></italic> AVJs was utilized to identify accessible regions within the <italic>Tbx3</italic> locus. As genome-wide peak-calling algorithms did not fully call all peaks within the <italic>Tbx3/Tbx5</italic> locus, even with less stringent parameters, we used a local, locus-specific threshold value for the selection of peaks. The entire sequence surpassing the threshold was included and considered as potential RE. A similar approach was used to select ventricular ATAC-seq regions (<xref ref-type="bibr" rid="bib78">van Duijvenboden et al., 2019</xref>), and a random selection of 67 regions from this set and the 67 accessible AVJ regions were used as input for the HOMER motif analysis tool (<xref ref-type="bibr" rid="bib33">Heinz et al., 2010</xref>) to identify AVCS-specific enriched sequence motifs within the <italic>Tbx3</italic> locus.</p><p>Murine/human STARR-seq regions with fold change of stimulation over control ofÂ &gt;1.5 (see: <italic>STARR-seq data analysis</italic>) were used as input for the HOMER motif analysis tool (<xref ref-type="bibr" rid="bib33">Heinz et al., 2010</xref>). Potential enrichment against genome background was checked for all known motifs in the JASPAR database (<xref ref-type="bibr" rid="bib25">Fornes et al., 2020</xref>). To allow for comparison of motif enrichment between different datasets, we used 150 randomly selected active regions for hSTARR_SG4 and hSTARR_Wnt, and 181 randomly selected active regions for mSTARR_SG4 and mSTARR_Wnt as input. Input regions were defined as the complete genomic region surpassing theÂ &gt;1.5 fold change threshold for activation over control.</p></sec><sec id="s4-8"><title>Cloning of RE candidates</title><p>Murine and human regions selected based on either STARR-seq activity or EMERGE/ATAC-seq prediction for validation were amplified from respective BAC DNA (used for STARR-seq library preparation) in which they reside. Major and minor haplotypes of identified RE candidates were amplified from human DNA from individuals within the CONCOR-genes database. PCR amplification of RE sequences was performed using Q5 Hot Start High-Fidelity DNA Polymerase (NEB; M0493S). Primer sequences are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Tables 7-9. Amplified sequences were ligated in the <italic>XcmI</italic> site of a modified pGL2-SV40 vector (Promega) using T4 DNA Ligase (ThermoFisher Scientific; 15224â090). After transformation, plasmid DNA was isolated using the PureLink HiPure Plasmid Midiprep kit (ThermoFisher Scientific; K210005) and purified by phenol/chloroform extraction.</p></sec><sec id="s4-9"><title>Cell culture</title><p>HL-1 cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0303">CVCL_0303</ext-link>; 2.5*10<sup>6</sup> cells/plate) were grown in 12-well plates in Claycomb medium (Sigma-Aldrich, 51800C) supplemented with chemically defined HL-1 FBS substitute (Lonza, 77227), Glutamax (ThermoFisher Scientific, 35050â061) and Pen/Strep (ThermoFisher Scientific, 15070â063). COS-7 cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0224">CVCL_0224</ext-link>; 1.5*10<sup>6</sup> cells/plate) were grown in 12-well plates in DMEM (ThermoFisher Scientific, 31966â021) supplemented with 10% FBS (ThermoFisher Scientific, 10270â106) and Pen/Strep (ThermoFisher Scientific, 15070â063). Both HL-1 and COS-7 cell lines were routinely tested negative for mycoplasma contamination. HL-1 cells and COS-7 cell lines were easily distinguished based on cellular morphology and contractility (HL-1). Neither HL-1 or COS-7 is found in the database of commonly misidentified cell lines that is maintained by the International Cell Line Authentication Committee.</p></sec><sec id="s4-10"><title>Transient transfection and luciferase assays</title><p>HL-1 cells were transfected with plasmid DNA using Lipofectamine 3000 (ThermoFisher Scientific, L3000-015). 1 Âµg plasmid DNA was transfected using 4 ÂµL P3000 reagent and 3 ÂµL Lipofectamine. COS-7 cells were transfected using Polyethylenimine 25 kDa (PEI; Sigma-Aldrich; 408727) at a 1:3 ratio (DNA:PEI). 1 Âµg of reporter plasmid DNA was transfected with either 500 ng of pcDNA3.1(+) (ThermoFisher Scientific, V790-20) as control, or 100 ng Smad1, 100 ng Smad4, 200 ng Alk3 and 100 ng Gata4 expression vectors (SG4) and 100 ng Tcf4, 400 ng pcDNA, and 0.4M LiCl (Wnt). Medium was refreshed 6 hr after transfection. Cells were lysed 48 hr after transfection using Renilla luciferase assay lysis buffer (Promega, E291A-C). Luciferase activity measurements were performed in duplo using a GloMax Explorer (Promega, GM3500) with 100 ul D-Luciferin (p.j.k., 102111). Measurements were performed by a 1 s delay and 5 s of measurement per sample.</p></sec><sec id="s4-11"><title>Analysis of disrupted/de novo created TF binding motifs in variant REs</title><p>Of the variant RE candidates of which the risk allele affected luciferase activity, we took the variant nucleotide and 10 nucleotides both up- and downstream. These 21 bp sequences were used as input for transcription factor binding motif recognition in JASPAR (<xref ref-type="bibr" rid="bib25">Fornes et al., 2020</xref>) using default settings.</p></sec><sec id="s4-12"><title>BAC modification and immunohistochemistry</title><p>The modification and analysis of BACs RP24-89K7-GFP, RP23-143N21-GFP and RP23-366H17-GFP has been previously described (<xref ref-type="bibr" rid="bib36">Horsthuis et al., 2009</xref>),(<xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>). BAC RP24-459M16 was obtained from a C57BL/6J mouse BAC library (CHORI, BACPAC Resources) and modified to generate 459M16-GFP. To this end, a GFP reporter gene cassette coupled to the minimal heat shock promoter 68 (hsp68-GFP) was inserted at 81 kb from the 5â-end of BAC 459M16 following the two-step BAC modification protocol as described in <xref ref-type="bibr" rid="bib30">Gong et al., 2002</xref>. Modified 459M16-GFP DNA was purified using the Nucleobond PC20 kit (Machery Nagel) and injected in pronuclei of FVB/N mice. Microinjected zygotes were implanted in pseudo-pregnant females (timepoint E0.5) and embryos were isolated at E13.5. GFP<sup>+</sup> embryos were fixed in 4% paraformaldehyde in PBS for 4 hr and processed for immunohistochemistry, as described in <xref ref-type="bibr" rid="bib82">van Weerd et al., 2014</xref>. Three independent GFP<sup>+</sup> founders were analysed for GFP expression.</p></sec><sec id="s4-13"><title>TALEN/CRISPR/Cas9-mediated genome editing of VR1 and VR2</title><p>For the deletion of VR1 from the mouse genome (<italic>Tbx3</italic><sup>âVR1</sup>), two genomic sites flanking were targeted by TALEN. TALEN target sequences were designed with TALENT2.0 (<ext-link ext-link-type="uri" xlink:href="https://tale-nt.cac.cornell.edu/">https://tale-nt.cac.cornell.edu/</ext-link>) and assembled according to the Golden Gate cloning protocol (<xref ref-type="bibr" rid="bib18">Cermak et al., 2011</xref>). Genomic coordinates and RVD sequences of TALEN target sites are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 4 (<xref ref-type="bibr" rid="bib17">Carlson et al., 2012</xref>).</p><p>Assembled RVDs were cloned in the pC-GoldyTALEN and RCIscript-GoldyTALEN (<xref ref-type="bibr" rid="bib17">Carlson et al., 2012</xref>) destination vector to generate mRNA expression plasmids. TALEN mRNA was in vitro transcribed by linearization of the expression plasmid with <italic>SacI</italic> at 37Â°C for 3 hr, followed by transcription of the linearized DNA using the T7 mMessage Machine kit (ThermoFisher Scientific; AM1344). 20 ng/Âµl of TALEN mRNA was injected in the cytoplasm of one-cell embryos of FVB/N mice. Positive founders were identified by PCR with primers flanking the 69 kb deletion and subsequent Sanger sequencing. The genomic deletion in positive founders was backcrossed for at least two generations with wildtype FVB/N mice before further experiments.</p><p>To delete VR2 from the mouse genome (<italic>Tbx3</italic><sup>âVR2</sup>), oligonucleotides for the generation of two single guide RNAs (sgRNAs) targeting two genomic sites flanking VR2 in the mouse genome were designed using the online tool ZiFit Targeter (<xref ref-type="bibr" rid="bib70">Sander et al., 2010</xref>). Target site sequences are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 5. sgRNA oligonucleotides were ligated into <italic>BsaI</italic>-digested pDR274 using T4 DNA Ligase (Invitrogen). sgRNA (pDR274) and Cas9 (MLM3613) expression vectors were linearized with <italic>DraI</italic> (NEB, R0129S) and <italic>PmeI</italic> (NEB, R0560S), respectively. sgRNA and Cas9 in vitro transcription was performed using the MEGAshort T7 kit (Life Technologies, AM1354) and mMessage mMachine T7 Ultra kit (Life Technologies, AM1345), respectively, followed by purification using the MEGAclear kit (Life Technologies, AM1908). 10 ng/Âµl sgRNA and 25 ng/Âµl Cas9 mRNA was micro-injected into the cytoplasm of one-cell embryos of FVB/N mice. The genomic deletion in positive founders was backcrossed for at least two generations with wildtype FVB/N mice before further experiments.</p></sec><sec id="s4-14"><title>In situ hybridization</title><p>E13.5 embryos were isolated in ice cold PBS and fixated overnight in 4% paraformaldehyde in PBS, dehydrated in a graded ethanol series, embedded in paraplast and sectioned at 10 Âµm. Non-radioactive in situ hybridization on sections was performed as previously described (<xref ref-type="bibr" rid="bib53">Moorman et al., 2001</xref>) using mRNA probes for the detection of <italic>Tbx3, Tbx5</italic> and <italic>Hcn4.</italic> Stained sections were examined with a Zeiss Axiophot microscope and photographed with a Leica DFC320 Digital Camera.</p></sec><sec id="s4-15"><title>Quantitative expression analysis</title><p>For the quantification of expression levels, E13.5 embryos from <italic>Tbx3<sup>+/+</sup>, Tbx3<sup>VR1/+</sup>, Tbx3<sup>VR2/+</sup>, Tbx3<sup>VR1/VR1</sup></italic> and <italic>Tbx3<sup>VR2/VR2</sup></italic> were isolated in ice cold PBS and liver, limbs, lungs, AVJs and SANs were isolated by microdissection. Total RNA was isolated by the ReliaPrep RNA Tissue Miniprep System (Promega; Z6112) according to manufacturerâs protocol. First-strand cDNA was synthesized with 500 ng total RNA as input using SuperScript II Reverse Transcriptase (ThermoFischer Scientific; 18064022). Quantitative real-timePCR was performed in technical duplicates using the Roche LightCycler 480 system. The oligonucleotide sequences for the amplification of the different amplicons are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>-Supplementary Table 6. The relative start concentration was calculated as described in <xref ref-type="bibr" rid="bib69">Ruijter et al., 2009</xref>. Expression values of the different amplicons were normalized to the geomean of <italic>Hprt</italic> and <italic>Eef2</italic> expression (liver, limbs, lungs), <italic>Tbx2</italic> expression (AVJ) and <italic>Isl1</italic> expression (SAN). Expression values in tissues of <italic>Tbx3<sup>VR1/+</sup>, Tbx3<sup>VR2/+</sup>, Tbx3<sup>VR1/VR1</sup></italic> and <italic>Tbx3<sup>VR2/VR2</sup></italic> mice were compared to those of wild-type littermates (<italic>Tbx3<sup>+/+</sup></italic>).</p></sec><sec id="s4-16"><title>Recording of in vivo and ex vivo electrocardiograms</title><p><italic>Tbx3</italic><sup>+/+</sup>, <italic>Tbx3</italic><sup>âVR1/âVR1</sup> <italic>and Tbx3</italic><sup>âVR2/âVR2</sup> mice (male, 2â4 months old) were anesthetized with 4% Isoflurane (Pharmachemie B.V.) and maintained at 1.5â2.0%. Electrodes were placed at the right (R) and left (L) armpit and the left groin (F) and an electrocardiogram (ECG) was recorded (PowerLab 26T; AD-Instruments, Colorado Springs, CO, USA) for a period of 5 min. ECG parameters were determined in Lead II (L-R) based on the last 30 s of the recording.</p><p>To record ECGs ex vivo the adult mice were sacrificed by CO<sub>2</sub> (1 L/min inflow) and cervical dislocation. The heart was rapidly excised, cannulated, mounted on a Langendorff perfusion set-up as described previouslyÂ (<xref ref-type="bibr" rid="bib13">Boukens et al., 2013</xref>). Neonatal mice (ND0-1) were sacrificed by 4% Isoflurane and cervical dislocation. Hearts were isolated and superfused with HEPES-buffered Tyrodeâs solution (containing in mmol/L: 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.5 glucose and 5.0 HEPES) at a temperature of 36 Â± 0.2Â°C; pH was set to 7.4 with NaOH. During perfusion the heart was submerged and electrodes were placed at the right (R) and left (L) side of the base of the heart and at the left side of the apex (F) at a 5 mm distance. Lead II was used to determine ECG parameters. ECG parameters both in vivo and ex vivo for <italic>Tbx3</italic><sup>âVR1/âVR1</sup> <italic>and Tbx3</italic><sup>âVR2/âVR2</sup> mice were compared to those of wild-type littermates (<italic>Tbx3</italic><sup>+/+</sup>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Corrie de Gier-de Vries for help with the in-situ hybridizations and Connie Bezzina and Doris Skoric-Milosavljevic for supplying human DNA samples for the amplification of RE haplotypes. This work was supported by the DutchÂ Heart Foundation/CVON project CONCORâgenes, Fondation Leducq (14CVD01) and DutchÂ Heart Foundation grant COBRA3 (2012T091) to VMC, and Dutch Heart Foundation grant 2016T047 to BJB.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal care and experiments were conducted in accordance with guidelines from the European Union, Dutch government, and Amsterdam University Medical Centers, and approved by the Animal Experimental Committee of the Amsterdam University Medical Centers and the Central Committee Animal Experiments (CCD) under AVD1180020172348.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary Tables 1â11.</title><p>Supplementary Table 1. Transcription factor binding motif enrichment in genomic regions accessible in E14.5 atrioventricular junctions. Transcription factor binding motif enrichment in 67 genomic regions accessible in E14.5 atrioventricular junctions (AVJ) or E14.5 ventricles. Enrichment was compared to enrichment in a number of random control sequences. Enrichment is depicted as total number of regions with the motif and the percentage of the total number of tested regions. P-values depict statistical significance of enrichment. Supplementary Table 2. Transcription factor binding motif enrichment in active STARR-regions.Â Transcription factor binding motif enrichment in genomic regions within both mouse (A) and human (B) <italic>TBX3</italic> locus that respond to Smad/Gata (SG4) or Tcf (Wnt) factors as demonstrated by STARR-seq. Enrichment of binding motifs for Smad/Gata- and Tcf-factors is depicted. Enrichment was compared to enrichment in a number of random control sequences. Enrichment is depicted as total number of regions with the motif and the percentage of the total number of tested regions. P-values depict statistical significance of enrichment. Supplementary Table 3. Murine RE candidates within VR1 and VR2.Â Murine RE candidates selected based on accessible chromatin in AV junction cardiomyocytes (ATAC_AVJ), EMERGE prediction, or mSTARR_SG4/Wnt activity. Overlap is depicted of candidate regions with ChIP-seq peaks from publicly available datasets for Gata4 (differentiated cardiomyocytes) (<xref ref-type="bibr" rid="bib47">Luna-Zurita et al., 2016</xref>), Hand2 (E10.5 heart) (<xref ref-type="bibr" rid="bib42">Laurent et al., 2017</xref>) and H3K27ac (E11.5 heart) (<xref ref-type="bibr" rid="bib58">Nord et al., 2013</xref>). Supplementary Table 4. Human RE candidates within VR1 and VR2.Â Human RE candidates selected based on mouse RE homology (mm9 liftover), EMERGE prediction, or hSTARR_SG4/Wnt activity. Regions overlapping GWAS SNPs (SNP id, trait association and respective p-value are listed) were selected for further analysis. Supplementary Table 5. TALEN/CRISPR target sequences for deletion of VR1 and VR2 from the murine genome Supplementary Table 6. qPCR primer sequences Supplementary Table 7. Overview of BACs used for the generation of STARR-seq libraries Supplementary Table 8. Primer sequences for the amplification of active STARR-seq regions for validation by luciferase reporter assay Supplementary Table 9. Primer sequences for the amplification of RE candidate fragments Supplementary Table 10. Mouse functional genomic datasets included in merge as possible predictors Supplementary Table 11. Human functional genomic datasets included in merge as possible predictors.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-56697-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-56697-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE121464 and GSE145257.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>vanÂ Weerd</surname><given-names>JH</given-names></name><name><surname>vanÂ Duijvenboden</surname><given-names>K</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>STARR-seq of human and mouse Tbx3 locus</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE125257">GSE125257</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>RA</given-names></name><name><surname>vanÂ Weerd</surname><given-names>JH</given-names></name><name><surname>vanÂ Duijvenboden</surname><given-names>K</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Tbx3 governs a transcriptional program to maintain atrioventricular conduction system form and function [ATAC-seq]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121464">GSE121464</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aanhaanen</surname> <given-names>WT</given-names></name><name><surname>Mommersteeg</surname> <given-names>MT</given-names></name><name><surname>Norden</surname> <given-names>J</given-names></name><name><surname>Wakker</surname> <given-names>V</given-names></name><name><surname>de Gier-de Vries</surname> <given-names>C</given-names></name><name><surname>Anderson</surname> <given-names>RH</given-names></name><name><surname>Kispert</surname> <given-names>A</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Developmental origin, growth, and three-dimensional architecture of the atrioventricular conduction Axis of the mouse heart</article-title><source>Circulation Research</source><volume>107</volume><fpage>728</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.222992</pub-id><pub-id pub-id-type="pmid">20671237</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aeschbacher</surname> <given-names>S</given-names></name><name><surname>O'Neal</surname> <given-names>WT</given-names></name><name><surname>Krisai</surname> <given-names>P</given-names></name><name><surname>Loehr</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>LY</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Conen</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Relationship between QRS duration and incident atrial fibrillation</article-title><source>International Journal of Cardiology</source><volume>266</volume><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2018.03.050</pub-id><pub-id pub-id-type="pmid">29887479</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname> <given-names>CD</given-names></name><name><surname>Gerlach</surname> <given-names>D</given-names></name><name><surname>Stelzer</surname> <given-names>C</given-names></name><name><surname>BoryÅ</surname> <given-names>ÅM</given-names></name><name><surname>Rath</surname> <given-names>M</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide quantitative enhancer activity maps identified by STARR-seq</article-title><source>Science</source><volume>339</volume><fpage>1074</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1126/science.1232542</pub-id><pub-id pub-id-type="pmid">23328393</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname> <given-names>CD</given-names></name><name><surname>Zabidi</surname> <given-names>MA</given-names></name><name><surname>Pagani</surname> <given-names>M</given-names></name><name><surname>Rath</surname> <given-names>M</given-names></name><name><surname>Schernhuber</surname> <given-names>K</given-names></name><name><surname>Kazmar</surname> <given-names>T</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome-wide assessment of sequence-intrinsic enhancer responsiveness at single-base-pair resolution</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1038/nbt.3739</pub-id><pub-id pub-id-type="pmid">28024147</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnolds</surname> <given-names>DE</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Fahrenbach</surname> <given-names>JP</given-names></name><name><surname>Kim</surname> <given-names>GH</given-names></name><name><surname>Schillinger</surname> <given-names>KJ</given-names></name><name><surname>Smemo</surname> <given-names>S</given-names></name><name><surname>McNally</surname> <given-names>EM</given-names></name><name><surname>Nobrega</surname> <given-names>MA</given-names></name><name><surname>Patel</surname> <given-names>VV</given-names></name><name><surname>Moskowitz</surname> <given-names>IP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TBX5 drives Scn5a expression to regulate cardiac conduction system function</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>2509</fpage><lpage>2518</lpage><pub-id pub-id-type="doi">10.1172/JCI62617</pub-id><pub-id pub-id-type="pmid">22728936</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadollahi</surname> <given-names>R</given-names></name><name><surname>Oneda</surname> <given-names>B</given-names></name><name><surname>Sheth</surname> <given-names>F</given-names></name><name><surname>Azzarello-Burri</surname> <given-names>S</given-names></name><name><surname>Baldinger</surname> <given-names>R</given-names></name><name><surname>Joset</surname> <given-names>P</given-names></name><name><surname>Latal</surname> <given-names>B</given-names></name><name><surname>Knirsch</surname> <given-names>W</given-names></name><name><surname>Desai</surname> <given-names>S</given-names></name><name><surname>Baumer</surname> <given-names>A</given-names></name><name><surname>Houge</surname> <given-names>G</given-names></name><name><surname>Andrieux</surname> <given-names>J</given-names></name><name><surname>Rauch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability</article-title><source>European Journal of Human Genetics</source><volume>21</volume><fpage>1100</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2013.17</pub-id><pub-id pub-id-type="pmid">23403903</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname> <given-names>ML</given-names></name><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Mommersteeg</surname> <given-names>MT</given-names></name><name><surname>Brons</surname> <given-names>JF</given-names></name><name><surname>Wakker</surname> <given-names>V</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system</article-title><source>Circulation Research</source><volume>102</volume><fpage>1340</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.169565</pub-id><pub-id pub-id-type="pmid">18467625</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname> <given-names>ML</given-names></name><name><surname>Boink</surname> <given-names>GJ</given-names></name><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>van den Boogaard</surname> <given-names>M</given-names></name><name><surname>den Haan</surname> <given-names>AD</given-names></name><name><surname>Hoogaars</surname> <given-names>WM</given-names></name><name><surname>Buermans</surname> <given-names>HP</given-names></name><name><surname>de Bakker</surname> <given-names>JM</given-names></name><name><surname>Seppen</surname> <given-names>J</given-names></name><name><surname>Tan</surname> <given-names>HL</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells</article-title><source>Cardiovascular Research</source><volume>94</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvs120</pub-id><pub-id pub-id-type="pmid">22419669</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>RC</given-names></name><name><surname>Law</surname> <given-names>DJ</given-names></name><name><surname>Watkins</surname> <given-names>WC</given-names></name><name><surname>Krakowiak</surname> <given-names>PA</given-names></name><name><surname>Moore</surname> <given-names>ME</given-names></name><name><surname>Franceschini</surname> <given-names>P</given-names></name><name><surname>Lala</surname> <given-names>R</given-names></name><name><surname>Holmes</surname> <given-names>LB</given-names></name><name><surname>Gebuhr</surname> <given-names>TC</given-names></name><name><surname>Bruneau</surname> <given-names>BG</given-names></name><name><surname>Schinzel</surname> <given-names>A</given-names></name><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Seidman</surname> <given-names>CE</given-names></name><name><surname>Jorde</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome</article-title><source>Nature Genetics</source><volume>16</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/ng0797-311</pub-id><pub-id pub-id-type="pmid">9207801</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basson</surname> <given-names>CT</given-names></name><name><surname>Huang</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>RC</given-names></name><name><surname>Bachinsky</surname> <given-names>DR</given-names></name><name><surname>Weremowicz</surname> <given-names>S</given-names></name><name><surname>Vaglio</surname> <given-names>A</given-names></name><name><surname>Bruzzone</surname> <given-names>R</given-names></name><name><surname>Quadrelli</surname> <given-names>R</given-names></name><name><surname>Lerone</surname> <given-names>M</given-names></name><name><surname>Romeo</surname> <given-names>G</given-names></name><name><surname>Silengo</surname> <given-names>M</given-names></name><name><surname>Pereira</surname> <given-names>A</given-names></name><name><surname>Krieger</surname> <given-names>J</given-names></name><name><surname>Mesquita</surname> <given-names>SF</given-names></name><name><surname>Kamisago</surname> <given-names>M</given-names></name><name><surname>Morton</surname> <given-names>CC</given-names></name><name><surname>Pierpont</surname> <given-names>ME</given-names></name><name><surname>MÃ¼ller</surname> <given-names>CW</given-names></name><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Seidman</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Different <italic>TBX5</italic> interactions in heart and limb defined by Holt-Oram syndrome mutations</article-title><source>PNAS</source><volume>96</volume><fpage>2919</fpage><lpage>2924</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.6.2919</pub-id><pub-id pub-id-type="pmid">10077612</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname> <given-names>S</given-names></name><name><surname>Munshi</surname> <given-names>NV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Development of the cardiac conduction system</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>18</volume><elocation-id>a037408</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a037408</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birket</surname> <given-names>MJ</given-names></name><name><surname>Ribeiro</surname> <given-names>MC</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>Ward</surname> <given-names>D</given-names></name><name><surname>Leitoguinho</surname> <given-names>AR</given-names></name><name><surname>den Hartogh</surname> <given-names>SC</given-names></name><name><surname>Orlova</surname> <given-names>VV</given-names></name><name><surname>Devalla</surname> <given-names>HD</given-names></name><name><surname>Schwach</surname> <given-names>V</given-names></name><name><surname>Bellin</surname> <given-names>M</given-names></name><name><surname>Passier</surname> <given-names>R</given-names></name><name><surname>Mummery</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>970</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1038/nbt.3271</pub-id><pub-id pub-id-type="pmid">26192318</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Hoogendijk</surname> <given-names>MG</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>Linnenbank</surname> <given-names>A</given-names></name><name><surname>van Dam</surname> <given-names>P</given-names></name><name><surname>Remme</surname> <given-names>CA</given-names></name><name><surname>Fiolet</surname> <given-names>JW</given-names></name><name><surname>Opthof</surname> <given-names>T</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Coronel</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Early repolarization in mice causes overestimation of ventricular activation time by the QRS duration</article-title><source>Cardiovascular Research</source><volume>97</volume><fpage>182</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvs299</pub-id><pub-id pub-id-type="pmid">22997159</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Zaba</surname> <given-names>LC</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title><source>Nature Methods</source><volume>10</volume><fpage>1213</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id><pub-id pub-id-type="pmid">24097267</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnicka-Turek</surname> <given-names>O</given-names></name><name><surname>Broman</surname> <given-names>MT</given-names></name><name><surname>Steimle</surname> <given-names>JD</given-names></name><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Petrenko</surname> <given-names>N</given-names></name><name><surname>Ikegami</surname> <given-names>K</given-names></name><name><surname>Nadadur</surname> <given-names>RD</given-names></name><name><surname>Qiao</surname> <given-names>Y</given-names></name><name><surname>Arnolds</surname> <given-names>DE</given-names></name><name><surname>Yang</surname> <given-names>XH</given-names></name><name><surname>Patel</surname> <given-names>VV</given-names></name><name><surname>Nobrega</surname> <given-names>MA</given-names></name><name><surname>Efimov</surname> <given-names>IR</given-names></name><name><surname>Moskowitz</surname> <given-names>IP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional patterning of the ventricular cardiac conduction system</article-title><source>Circulation Research</source><volume>113</volume><elocation-id>314460</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.314460</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>CannavÃ²</surname> <given-names>E</given-names></name><name><surname>Khoueiry</surname> <given-names>P</given-names></name><name><surname>Garfield</surname> <given-names>DA</given-names></name><name><surname>Geeleher</surname> <given-names>P</given-names></name><name><surname>Zichner</surname> <given-names>T</given-names></name><name><surname>Gustafson</surname> <given-names>EH</given-names></name><name><surname>Ciglar</surname> <given-names>L</given-names></name><name><surname>Korbel</surname> <given-names>JO</given-names></name><name><surname>Furlong</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Shadow enhancers are pervasive features of developmental regulatory networks</article-title><source>Current Biology</source><volume>26</volume><fpage>38</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.11.034</pub-id><pub-id pub-id-type="pmid">26687625</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname> <given-names>DF</given-names></name><name><surname>Tan</surname> <given-names>W</given-names></name><name><surname>Lillico</surname> <given-names>SG</given-names></name><name><surname>Stverakova</surname> <given-names>D</given-names></name><name><surname>Proudfoot</surname> <given-names>C</given-names></name><name><surname>Christian</surname> <given-names>M</given-names></name><name><surname>Voytas</surname> <given-names>DF</given-names></name><name><surname>Long</surname> <given-names>CR</given-names></name><name><surname>Whitelaw</surname> <given-names>CB</given-names></name><name><surname>Fahrenkrug</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Efficient TALEN-mediated gene knockout in livestock</article-title><source>PNAS</source><volume>109</volume><fpage>17382</fpage><lpage>17387</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211446109</pub-id><pub-id pub-id-type="pmid">23027955</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cermak</surname> <given-names>T</given-names></name><name><surname>Doyle</surname> <given-names>EL</given-names></name><name><surname>Christian</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Schmidt</surname> <given-names>C</given-names></name><name><surname>Baller</surname> <given-names>JA</given-names></name><name><surname>Somia</surname> <given-names>NV</given-names></name><name><surname>Bogdanove</surname> <given-names>AJ</given-names></name><name><surname>Voytas</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting</article-title><source>Nucleic Acids Research</source><volume>39</volume><elocation-id>7879</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkr739</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>S</given-names></name><name><surname>Keyes</surname> <given-names>MJ</given-names></name><name><surname>Larson</surname> <given-names>MG</given-names></name><name><surname>McCabe</surname> <given-names>EL</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Benjamin</surname> <given-names>EJ</given-names></name><name><surname>Vasan</surname> <given-names>RS</given-names></name><name><surname>Wang</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block</article-title><source>Jama</source><volume>301</volume><elocation-id>2571</elocation-id><pub-id pub-id-type="doi">10.1001/jama.2009.888</pub-id><pub-id pub-id-type="pmid">19549974</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claycomb</surname> <given-names>WC</given-names></name><name><surname>Lanson</surname> <given-names>NA</given-names></name><name><surname>Stallworth</surname> <given-names>BS</given-names></name><name><surname>Egeland</surname> <given-names>DB</given-names></name><name><surname>Delcarpio</surname> <given-names>JB</given-names></name><name><surname>Bahinski</surname> <given-names>A</given-names></name><name><surname>Izzo</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte</article-title><source>PNAS</source><volume>95</volume><fpage>2979</fpage><lpage>2984</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.6.2979</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradin</surname> <given-names>O</given-names></name><name><surname>Scacheri</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Enhancer variants: evaluating functions in common disease</article-title><source>Genome Medicine</source><volume>6</volume><elocation-id>85</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-014-0085-3</pub-id><pub-id pub-id-type="pmid">25473424</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname> <given-names>TG</given-names></name><name><surname>Jerome-Majewska</surname> <given-names>LA</given-names></name><name><surname>Papaioannou</surname> <given-names>VE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome</article-title><source>Development</source><volume>130</volume><fpage>2263</fpage><lpage>2273</lpage><pub-id pub-id-type="doi">10.1242/dev.00431</pub-id><pub-id pub-id-type="pmid">12668638</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>Vos</surname> <given-names>ES</given-names></name><name><surname>Holwerda</surname> <given-names>SJ</given-names></name><name><surname>Valdes-Quezada</surname> <given-names>C</given-names></name><name><surname>Verstegen</surname> <given-names>MJ</given-names></name><name><surname>Teunissen</surname> <given-names>H</given-names></name><name><surname>Splinter</surname> <given-names>E</given-names></name><name><surname>Wijchers</surname> <given-names>PJ</given-names></name><name><surname>Krijger</surname> <given-names>PH</given-names></name><name><surname>de Laat</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CTCF binding polarity determines chromatin looping</article-title><source>Molecular Cell</source><volume>60</volume><fpage>676</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.023</pub-id><pub-id pub-id-type="pmid">26527277</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deplancke</surname> <given-names>B</given-names></name><name><surname>Alpern</surname> <given-names>D</given-names></name><name><surname>Gardeux</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The genetics of transcription factor DNA binding variation</article-title><source>Cell</source><volume>166</volume><fpage>538</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.012</pub-id><pub-id pub-id-type="pmid">27471964</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornes</surname> <given-names>O</given-names></name><name><surname>Castro-Mondragon</surname> <given-names>JA</given-names></name><name><surname>Khan</surname> <given-names>A</given-names></name><name><surname>van der Lee</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Richmond</surname> <given-names>PA</given-names></name><name><surname>Mathelier</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title><source>Nucleic Acids Research</source><volume>8</volume><fpage>D87</fpage><lpage>D92</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1001</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>DU</given-names></name><name><surname>Carter</surname> <given-names>KL</given-names></name><name><surname>Thomas</surname> <given-names>KR</given-names></name><name><surname>Burr</surname> <given-names>RM</given-names></name><name><surname>Bakker</surname> <given-names>ML</given-names></name><name><surname>Coetzee</surname> <given-names>WA</given-names></name><name><surname>Tristani-Firouzi</surname> <given-names>M</given-names></name><name><surname>Bamshad</surname> <given-names>MJ</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Moon</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lethal arrhythmias in Tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasis</article-title><source>PNAS</source><volume>109</volume><fpage>E154</fpage><lpage>E156</lpage><pub-id pub-id-type="doi">10.1073/pnas.1115165109</pub-id><pub-id pub-id-type="pmid">22203979</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname> <given-names>MD</given-names></name><name><surname>Chen-Plotkin</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Post-GWAS era: from association to function</article-title><source>The American Journal of Human Genetics</source><volume>102</volume><fpage>717</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.04.002</pub-id><pub-id pub-id-type="pmid">29727686</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillers</surname> <given-names>BS</given-names></name><name><surname>Chiplunkar</surname> <given-names>A</given-names></name><name><surname>Aly</surname> <given-names>H</given-names></name><name><surname>Valenta</surname> <given-names>T</given-names></name><name><surname>Basler</surname> <given-names>K</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Efimov</surname> <given-names>IR</given-names></name><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Rentschler</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Canonical wnt signaling regulates atrioventricular junction programming and electrophysiological properties</article-title><source>Circulation Research</source><volume>116</volume><fpage>398</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.304731</pub-id><pub-id pub-id-type="pmid">25599332</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilsbach</surname> <given-names>R</given-names></name><name><surname>Preissl</surname> <given-names>S</given-names></name><name><surname>GrÃ¼ning</surname> <given-names>BA</given-names></name><name><surname>Schnick</surname> <given-names>T</given-names></name><name><surname>Burger</surname> <given-names>L</given-names></name><name><surname>Benes</surname> <given-names>V</given-names></name><name><surname>WÃ¼rch</surname> <given-names>A</given-names></name><name><surname>BÃ¶nisch</surname> <given-names>U</given-names></name><name><surname>GÃ¼nther</surname> <given-names>S</given-names></name><name><surname>Backofen</surname> <given-names>R</given-names></name><name><surname>Fleischmann</surname> <given-names>BK</given-names></name><name><surname>SchÃ¼beler</surname> <given-names>D</given-names></name><name><surname>Hein</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5288</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6288</pub-id><pub-id pub-id-type="pmid">25335909</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>XW</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Heintz</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication</article-title><source>Genome Research</source><volume>12</volume><fpage>1992</fpage><lpage>1998</lpage><pub-id pub-id-type="doi">10.1101/gr.476202</pub-id><pub-id pub-id-type="pmid">12466304</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname> <given-names>A</given-names></name><name><surname>Chung</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomics of atrial fibrillation</article-title><source>Current Cardiology Reports</source><volume>18</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.1007/s11886-016-0735-8</pub-id><pub-id pub-id-type="pmid">27139902</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heintzman</surname> <given-names>ND</given-names></name><name><surname>Hon</surname> <given-names>GC</given-names></name><name><surname>Hawkins</surname> <given-names>RD</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name><name><surname>Harp</surname> <given-names>LF</given-names></name><name><surname>Ye</surname> <given-names>Z</given-names></name><name><surname>Lee</surname> <given-names>LK</given-names></name><name><surname>Stuart</surname> <given-names>RK</given-names></name><name><surname>Ching</surname> <given-names>CW</given-names></name><name><surname>Ching</surname> <given-names>KA</given-names></name><name><surname>Antosiewicz-Bourget</surname> <given-names>JE</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Green</surname> <given-names>RD</given-names></name><name><surname>Lobanenkov</surname> <given-names>VV</given-names></name><name><surname>Stewart</surname> <given-names>R</given-names></name><name><surname>Thomson</surname> <given-names>JA</given-names></name><name><surname>Crawford</surname> <given-names>GE</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Histone modifications at human enhancers reflect global cell-type-specific gene expression</article-title><source>Nature</source><volume>459</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nature07829</pub-id><pub-id pub-id-type="pmid">19295514</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname> <given-names>S</given-names></name><name><surname>Benner</surname> <given-names>C</given-names></name><name><surname>Spann</surname> <given-names>N</given-names></name><name><surname>Bertolino</surname> <given-names>E</given-names></name><name><surname>Lin</surname> <given-names>YC</given-names></name><name><surname>Laslo</surname> <given-names>P</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Glass</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogaars</surname> <given-names>WM</given-names></name><name><surname>Tessari</surname> <given-names>A</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>de Boer</surname> <given-names>PA</given-names></name><name><surname>Hagoort</surname> <given-names>J</given-names></name><name><surname>Soufan</surname> <given-names>AT</given-names></name><name><surname>Campione</surname> <given-names>M</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart</article-title><source>Cardiovascular Research</source><volume>62</volume><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.01.030</pub-id><pub-id pub-id-type="pmid">15158141</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogaars</surname> <given-names>WM</given-names></name><name><surname>Engel</surname> <given-names>A</given-names></name><name><surname>Brons</surname> <given-names>JF</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>de Lange</surname> <given-names>FJ</given-names></name><name><surname>Wong</surname> <given-names>LY</given-names></name><name><surname>Bakker</surname> <given-names>ML</given-names></name><name><surname>Clout</surname> <given-names>DE</given-names></name><name><surname>Wakker</surname> <given-names>V</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Ravesloot</surname> <given-names>JH</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>Verheijck</surname> <given-names>EE</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>1098</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1101/gad.416007</pub-id><pub-id pub-id-type="pmid">17473172</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsthuis</surname> <given-names>T</given-names></name><name><surname>Buermans</surname> <given-names>HP</given-names></name><name><surname>Brons</surname> <given-names>JF</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>Bakker</surname> <given-names>ML</given-names></name><name><surname>Wakker</surname> <given-names>V</given-names></name><name><surname>Clout</surname> <given-names>DE</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Gene expression profiling of the forming atrioventricular node using a novel tbx3-based node-specific transgenic reporter</article-title><source>Circulation Research</source><volume>105</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.192443</pub-id><pub-id pub-id-type="pmid">19498200</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>J</given-names></name><name><surname>Gore-Panter</surname> <given-names>S</given-names></name><name><surname>Tchou</surname> <given-names>G</given-names></name><name><surname>Castel</surname> <given-names>L</given-names></name><name><surname>Lovano</surname> <given-names>B</given-names></name><name><surname>Moravec</surname> <given-names>CS</given-names></name><name><surname>Pettersson</surname> <given-names>GB</given-names></name><name><surname>Roselli</surname> <given-names>EE</given-names></name><name><surname>Gillinov</surname> <given-names>AM</given-names></name><name><surname>McCurry</surname> <given-names>KR</given-names></name><name><surname>Smedira</surname> <given-names>NG</given-names></name><name><surname>Barnard</surname> <given-names>J</given-names></name><name><surname>Van Wagoner</surname> <given-names>DR</given-names></name><name><surname>Chung</surname> <given-names>MK</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic control of left atrial gene expression yields insights into the genetic susceptibility for atrial fibrillation</article-title><source>Circulation. Genomic and Precision Medicine</source><volume>11</volume><elocation-id>e002107</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCGEN.118.002107</pub-id><pub-id pub-id-type="pmid">29545482</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>F</given-names></name><name><surname>Ahituv</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Decoding enhancers using massively parallel reporter assays</article-title><source>Genomics</source><volume>106</volume><fpage>159</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2015.06.005</pub-id><pub-id pub-id-type="pmid">26072433</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inukai</surname> <given-names>S</given-names></name><name><surname>Kock</surname> <given-names>KH</given-names></name><name><surname>Bulyk</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcription factor-DNA binding: beyond binding site motifs</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>43</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2017.02.007</pub-id><pub-id pub-id-type="pmid">28359978</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>JJ</given-names></name><name><surname>Husse</surname> <given-names>B</given-names></name><name><surname>Rimmbach</surname> <given-names>C</given-names></name><name><surname>Krebs</surname> <given-names>S</given-names></name><name><surname>Stieber</surname> <given-names>J</given-names></name><name><surname>Steinhoff</surname> <given-names>G</given-names></name><name><surname>Dendorfer</surname> <given-names>A</given-names></name><name><surname>Franz</surname> <given-names>WM</given-names></name><name><surname>David</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells</article-title><source>Stem Cell Reports</source><volume>2</volume><fpage>592</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.03.006</pub-id><pub-id pub-id-type="pmid">24936448</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname> <given-names>WJ</given-names></name><name><surname>Sugnet</surname> <given-names>CW</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Roskin</surname> <given-names>KM</given-names></name><name><surname>Pringle</surname> <given-names>TH</given-names></name><name><surname>Zahler</surname> <given-names>AM</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The human genome browser at UCSC</article-title><source>Genome Research</source><volume>12</volume><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1101/gr.229102</pub-id><pub-id pub-id-type="pmid">12045153</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname> <given-names>F</given-names></name><name><surname>Girdziusaite</surname> <given-names>A</given-names></name><name><surname>Gamart</surname> <given-names>J</given-names></name><name><surname>Barozzi</surname> <given-names>I</given-names></name><name><surname>Osterwalder</surname> <given-names>M</given-names></name><name><surname>Akiyama</surname> <given-names>JA</given-names></name><name><surname>Lincoln</surname> <given-names>J</given-names></name><name><surname>Lopez-Rios</surname> <given-names>J</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name><name><surname>Zuniga</surname> <given-names>A</given-names></name><name><surname>Zeller</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HAND2 target gene regulatory networks control atrioventricular canal and cardiac valve development</article-title><source>Cell Reports</source><volume>19</volume><fpage>1602</fpage><lpage>1613</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.004</pub-id><pub-id pub-id-type="pmid">28538179</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname> <given-names>HK</given-names></name><name><surname>Prescott</surname> <given-names>SL</given-names></name><name><surname>Wysocka</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ever-Changing landscapes: transcriptional enhancers in development and evolution</article-title><source>Cell</source><volume>167</volume><fpage>1170</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.018</pub-id><pub-id pub-id-type="pmid">27863239</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LÃ¼dtke</surname> <given-names>TH</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Petry</surname> <given-names>M</given-names></name><name><surname>Kispert</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation</article-title><source>Hepatology</source><volume>49</volume><fpage>969</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1002/hep.22700</pub-id><pub-id pub-id-type="pmid">19140222</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LÃ¼dtke</surname> <given-names>TH</given-names></name><name><surname>Farin</surname> <given-names>HF</given-names></name><name><surname>Rudat</surname> <given-names>C</given-names></name><name><surname>Schuster-Gossler</surname> <given-names>K</given-names></name><name><surname>Petry</surname> <given-names>M</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Kispert</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003189</pub-id><pub-id pub-id-type="pmid">23341776</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luna-Zurita</surname> <given-names>L</given-names></name><name><surname>Stirnimann</surname> <given-names>CU</given-names></name><name><surname>Glatt</surname> <given-names>S</given-names></name><name><surname>Kaynak</surname> <given-names>BL</given-names></name><name><surname>Thomas</surname> <given-names>S</given-names></name><name><surname>Baudin</surname> <given-names>F</given-names></name><name><surname>Samee</surname> <given-names>MA</given-names></name><name><surname>He</surname> <given-names>D</given-names></name><name><surname>Small</surname> <given-names>EM</given-names></name><name><surname>Mileikovsky</surname> <given-names>M</given-names></name><name><surname>Nagy</surname> <given-names>A</given-names></name><name><surname>Holloway</surname> <given-names>AK</given-names></name><name><surname>Pollard</surname> <given-names>KS</given-names></name><name><surname>MÃ¼ller</surname> <given-names>CW</given-names></name><name><surname>Bruneau</surname> <given-names>BG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Complex interdependence regulates heterotypic transcription factor distribution and coordinates cardiogenesis</article-title><source>Cell</source><volume>164</volume><fpage>999</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.01.004</pub-id><pub-id pub-id-type="pmid">26875865</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machiela</surname> <given-names>MJ</given-names></name><name><surname>Chanock</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants</article-title><source>Bioinformatics</source><volume>31</volume><fpage>3555</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv402</pub-id><pub-id pub-id-type="pmid">26139635</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolio</surname> <given-names>TA</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Cox</surname> <given-names>NJ</given-names></name><name><surname>Goldstein</surname> <given-names>DB</given-names></name><name><surname>Hindorff</surname> <given-names>LA</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Ramos</surname> <given-names>EM</given-names></name><name><surname>Cardon</surname> <given-names>LR</given-names></name><name><surname>Chakravarti</surname> <given-names>A</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Guttmacher</surname> <given-names>AE</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Kruglyak</surname> <given-names>L</given-names></name><name><surname>Mardis</surname> <given-names>E</given-names></name><name><surname>Rotimi</surname> <given-names>CN</given-names></name><name><surname>Slatkin</surname> <given-names>M</given-names></name><name><surname>Valle</surname> <given-names>D</given-names></name><name><surname>Whittemore</surname> <given-names>AS</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Clark</surname> <given-names>AG</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Gibson</surname> <given-names>G</given-names></name><name><surname>Haines</surname> <given-names>JL</given-names></name><name><surname>Mackay</surname> <given-names>TFC</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name><name><surname>Visscher</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Finding the missing heritability of complex diseases</article-title><source>Nature</source><volume>461</volume><fpage>747</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1038/nature08494</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maston</surname> <given-names>GA</given-names></name><name><surname>Evans</surname> <given-names>SK</given-names></name><name><surname>Green</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Transcriptional regulatory elements in the human genome</article-title><source>Annual Review of Genomics and Human Genetics</source><volume>7</volume><fpage>29</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1146/annurev.genom.7.080505.115623</pub-id><pub-id pub-id-type="pmid">16719718</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Humbert</surname> <given-names>R</given-names></name><name><surname>Rynes</surname> <given-names>E</given-names></name><name><surname>Thurman</surname> <given-names>RE</given-names></name><name><surname>Haugen</surname> <given-names>E</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Reynolds</surname> <given-names>AP</given-names></name><name><surname>Sandstrom</surname> <given-names>R</given-names></name><name><surname>Qu</surname> <given-names>H</given-names></name><name><surname>Brody</surname> <given-names>J</given-names></name><name><surname>Shafer</surname> <given-names>A</given-names></name><name><surname>Neri</surname> <given-names>F</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>Kutyavin</surname> <given-names>T</given-names></name><name><surname>Stehling-Sun</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>AK</given-names></name><name><surname>Canfield</surname> <given-names>TK</given-names></name><name><surname>Giste</surname> <given-names>E</given-names></name><name><surname>Diegel</surname> <given-names>M</given-names></name><name><surname>Bates</surname> <given-names>D</given-names></name><name><surname>Hansen</surname> <given-names>RS</given-names></name><name><surname>Neph</surname> <given-names>S</given-names></name><name><surname>Sabo</surname> <given-names>PJ</given-names></name><name><surname>Heimfeld</surname> <given-names>S</given-names></name><name><surname>Raubitschek</surname> <given-names>A</given-names></name><name><surname>Ziegler</surname> <given-names>S</given-names></name><name><surname>Cotsapas</surname> <given-names>C</given-names></name><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name><name><surname>Glass</surname> <given-names>I</given-names></name><name><surname>Sunyaev</surname> <given-names>SR</given-names></name><name><surname>Kaul</surname> <given-names>R</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Systematic localization of common disease-associated variation in regulatory DNA</article-title><source>Science</source><volume>337</volume><fpage>1190</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1126/science.1222794</pub-id><pub-id pub-id-type="pmid">22955828</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Cardon</surname> <given-names>LR</given-names></name><name><surname>Goldstein</surname> <given-names>DB</given-names></name><name><surname>Little</surname> <given-names>J</given-names></name><name><surname>Ioannidis</surname> <given-names>JP</given-names></name><name><surname>Hirschhorn</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genome-wide association studies for complex traits: consensus, uncertainty and challenges</article-title><source>Nature Reviews Genetics</source><volume>9</volume><fpage>356</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1038/nrg2344</pub-id><pub-id pub-id-type="pmid">18398418</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>Houweling</surname> <given-names>AC</given-names></name><name><surname>de Boer</surname> <given-names>PA</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol</article-title><source>Journal of Histochemistry &amp; Cytochemistry</source><volume>49</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1177/002215540104900101</pub-id><pub-id pub-id-type="pmid">11118473</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorthy</surname> <given-names>SD</given-names></name><name><surname>Davidson</surname> <given-names>S</given-names></name><name><surname>Shchuka</surname> <given-names>VM</given-names></name><name><surname>Singh</surname> <given-names>G</given-names></name><name><surname>Malek-Gilani</surname> <given-names>N</given-names></name><name><surname>Langroudi</surname> <given-names>L</given-names></name><name><surname>Martchenko</surname> <given-names>A</given-names></name><name><surname>So</surname> <given-names>V</given-names></name><name><surname>Macpherson</surname> <given-names>NN</given-names></name><name><surname>Mitchell</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes</article-title><source>Genome Research</source><volume>27</volume><fpage>246</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1101/gr.210930.116</pub-id><pub-id pub-id-type="pmid">27895109</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozzetta</surname> <given-names>C</given-names></name><name><surname>Boyarchuk</surname> <given-names>E</given-names></name><name><surname>Pontis</surname> <given-names>J</given-names></name><name><surname>Ait-Si-Ali</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sound of silence: the properties and functions of repressive lys methyltransferases</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>16</volume><fpage>499</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/nrm4029</pub-id><pub-id pub-id-type="pmid">26204160</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muerdter</surname> <given-names>F</given-names></name><name><surname>BoryÅ</surname> <given-names>ÅM</given-names></name><name><surname>Woodfin</surname> <given-names>AR</given-names></name><name><surname>Neumayr</surname> <given-names>C</given-names></name><name><surname>Rath</surname> <given-names>M</given-names></name><name><surname>Zabidi</surname> <given-names>MA</given-names></name><name><surname>Pagani</surname> <given-names>M</given-names></name><name><surname>Haberle</surname> <given-names>V</given-names></name><name><surname>Kazmar</surname> <given-names>T</given-names></name><name><surname>Catarino</surname> <given-names>RR</given-names></name><name><surname>Schernhuber</surname> <given-names>K</given-names></name><name><surname>Arnold</surname> <given-names>CD</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Resolving systematic errors in widely used enhancer activity assays in human cells</article-title><source>Nature Methods</source><volume>15</volume><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4534</pub-id><pub-id pub-id-type="pmid">29256496</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nora</surname> <given-names>EP</given-names></name><name><surname>Goloborodko</surname> <given-names>A</given-names></name><name><surname>Valton</surname> <given-names>A-L</given-names></name><name><surname>Gibcus</surname> <given-names>JH</given-names></name><name><surname>Uebersohn</surname> <given-names>A</given-names></name><name><surname>Abdennur</surname> <given-names>N</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>Mirny</surname> <given-names>LA</given-names></name><name><surname>Bruneau</surname> <given-names>BG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Targeted degradation of CTCF decouples local insulation of chromosome domains from genomic compartmentalization</article-title><source>Cell</source><volume>169</volume><fpage>930</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.004</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nord</surname> <given-names>AS</given-names></name><name><surname>Blow</surname> <given-names>MJ</given-names></name><name><surname>Attanasio</surname> <given-names>C</given-names></name><name><surname>Akiyama</surname> <given-names>JA</given-names></name><name><surname>Holt</surname> <given-names>A</given-names></name><name><surname>Hosseini</surname> <given-names>R</given-names></name><name><surname>Phouanenavong</surname> <given-names>S</given-names></name><name><surname>Plajzer-Frick</surname> <given-names>I</given-names></name><name><surname>Shoukry</surname> <given-names>M</given-names></name><name><surname>Afzal</surname> <given-names>V</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Rubin</surname> <given-names>EM</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rapid and pervasive changes in genome-wide enhancer usage during mammalian development</article-title><source>Cell</source><volume>155</volume><fpage>1521</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.11.033</pub-id><pub-id pub-id-type="pmid">24360275</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterwalder</surname> <given-names>M</given-names></name><name><surname>Barozzi</surname> <given-names>I</given-names></name><name><surname>TissiÃ¨res</surname> <given-names>V</given-names></name><name><surname>Fukuda-Yuzawa</surname> <given-names>Y</given-names></name><name><surname>Mannion</surname> <given-names>BJ</given-names></name><name><surname>Afzal</surname> <given-names>SY</given-names></name><name><surname>Lee</surname> <given-names>EA</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Plajzer-Frick</surname> <given-names>I</given-names></name><name><surname>Pickle</surname> <given-names>CS</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Garvin</surname> <given-names>TH</given-names></name><name><surname>Pham</surname> <given-names>QT</given-names></name><name><surname>Harrington</surname> <given-names>AN</given-names></name><name><surname>Akiyama</surname> <given-names>JA</given-names></name><name><surname>Afzal</surname> <given-names>V</given-names></name><name><surname>Lopez-Rios</surname> <given-names>J</given-names></name><name><surname>Dickel</surname> <given-names>DE</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Enhancer redundancy provides phenotypic robustness in mammalian development</article-title><source>Nature</source><volume>554</volume><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1038/nature25461</pub-id><pub-id pub-id-type="pmid">29420474</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>DS</given-names></name><name><surname>Fishman</surname> <given-names>GI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Development and function of the cardiac conduction system in health and disease</article-title><source>Journal of Cardiovascular Development and Disease</source><volume>4</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.3390/jcdd4020007</pub-id><pub-id pub-id-type="pmid">29098150</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeufer</surname> <given-names>A</given-names></name><name><surname>van Noord</surname> <given-names>C</given-names></name><name><surname>Marciante</surname> <given-names>KD</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name><name><surname>Larson</surname> <given-names>MG</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Tarasov</surname> <given-names>KV</given-names></name><name><surname>MÃ¼ller</surname> <given-names>M</given-names></name><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name><name><surname>Sinner</surname> <given-names>MF</given-names></name><name><surname>Verwoert</surname> <given-names>GC</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>KÃ¶ttgen</surname> <given-names>A</given-names></name><name><surname>Coresh</surname> <given-names>J</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Rice</surname> <given-names>K</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Rivadeneira</surname> <given-names>F</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Kors</surname> <given-names>JA</given-names></name><name><surname>Stricker</surname> <given-names>BH</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Beckmann</surname> <given-names>BM</given-names></name><name><surname>Sauter</surname> <given-names>W</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Lubitz</surname> <given-names>SA</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>TJ</given-names></name><name><surname>Magnani</surname> <given-names>JW</given-names></name><name><surname>Schnabel</surname> <given-names>RB</given-names></name><name><surname>Chung</surname> <given-names>MK</given-names></name><name><surname>Barnard</surname> <given-names>J</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Van Wagoner</surname> <given-names>DR</given-names></name><name><surname>Vasan</surname> <given-names>RS</given-names></name><name><surname>Aspelund</surname> <given-names>T</given-names></name><name><surname>Eiriksdottir</surname> <given-names>G</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Launer</surname> <given-names>LJ</given-names></name><name><surname>Najjar</surname> <given-names>SS</given-names></name><name><surname>Lakatta</surname> <given-names>E</given-names></name><name><surname>Schlessinger</surname> <given-names>D</given-names></name><name><surname>Uda</surname> <given-names>M</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>MÃ¼ller-Myhsok</surname> <given-names>B</given-names></name><name><surname>Ehret</surname> <given-names>GB</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Chakravarti</surname> <given-names>A</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Lunetta</surname> <given-names>KL</given-names></name><name><surname>Perz</surname> <given-names>S</given-names></name><name><surname>Wichmann</surname> <given-names>HE</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>Sanna</surname> <given-names>S</given-names></name><name><surname>KÃ¤Ã¤b</surname> <given-names>S</given-names></name><name><surname>Witteman</surname> <given-names>JC</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Benjamin</surname> <given-names>EJ</given-names></name><name><surname>Heckbert</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome-wide association study of PR interval</article-title><source>Nature Genetics</source><volume>42</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1038/ng.517</pub-id><pub-id pub-id-type="pmid">20062060</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protze</surname> <given-names>SI</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Nussinovitch</surname> <given-names>U</given-names></name><name><surname>Ohana</surname> <given-names>L</given-names></name><name><surname>Backx</surname> <given-names>PH</given-names></name><name><surname>Gepstein</surname> <given-names>L</given-names></name><name><surname>Keller</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>56</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nbt.3745</pub-id><pub-id pub-id-type="pmid">27941801</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>AR</given-names></name><name><surname>Hall</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>RamÃ­rez</surname> <given-names>F</given-names></name><name><surname>Ryan</surname> <given-names>DP</given-names></name><name><surname>GrÃ¼ning</surname> <given-names>B</given-names></name><name><surname>Bhardwaj</surname> <given-names>V</given-names></name><name><surname>Kilpert</surname> <given-names>F</given-names></name><name><surname>Richter</surname> <given-names>AS</given-names></name><name><surname>Heyne</surname> <given-names>S</given-names></name><name><surname>DÃ¼ndar</surname> <given-names>F</given-names></name><name><surname>Manke</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>deepTools2: a next generation web server for deep-sequencing data analysis</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W160</fpage><lpage>W165</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw257</pub-id><pub-id pub-id-type="pmid">27079975</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>RamÃ­rez</surname> <given-names>J</given-names></name><name><surname>Duijvenboden</surname> <given-names>SV</given-names></name><name><surname>Ntalla</surname> <given-names>I</given-names></name><name><surname>Mifsud</surname> <given-names>B</given-names></name><name><surname>Warren</surname> <given-names>HR</given-names></name><name><surname>Tzanis</surname> <given-names>E</given-names></name><name><surname>Orini</surname> <given-names>M</given-names></name><name><surname>Tinker</surname> <given-names>A</given-names></name><name><surname>Lambiase</surname> <given-names>PD</given-names></name><name><surname>Munroe</surname> <given-names>PB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1947</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04148-1</pub-id><pub-id pub-id-type="pmid">29769521</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>SS</given-names></name><name><surname>Huntley</surname> <given-names>MH</given-names></name><name><surname>Durand</surname> <given-names>NC</given-names></name><name><surname>Stamenova</surname> <given-names>EK</given-names></name><name><surname>Bochkov</surname> <given-names>ID</given-names></name><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Sanborn</surname> <given-names>AL</given-names></name><name><surname>Machol</surname> <given-names>I</given-names></name><name><surname>Omer</surname> <given-names>AD</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Aiden</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A 3D map of the human genome at Kilobase resolution reveals principles of chromatin looping</article-title><source>Cell</source><volume>159</volume><fpage>1665</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.021</pub-id><pub-id pub-id-type="pmid">25497547</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimmbach</surname> <given-names>C</given-names></name><name><surname>Jung</surname> <given-names>JJ</given-names></name><name><surname>David</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Generation of murine cardiac pacemaker cell aggregates based on ES-Cell-Programming in combination with Myh6-Promoter-Selection</article-title><source>Journal of Visualized Experiments</source><volume>96</volume><elocation-id>e52465</elocation-id><pub-id pub-id-type="doi">10.3791/52465</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roselli</surname> <given-names>C</given-names></name><name><surname>Chaffin</surname> <given-names>MD</given-names></name><name><surname>Weng</surname> <given-names>LC</given-names></name><name><surname>Aeschbacher</surname> <given-names>S</given-names></name><name><surname>Ahlberg</surname> <given-names>G</given-names></name><name><surname>Albert</surname> <given-names>CM</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Anderson</surname> <given-names>CD</given-names></name><name><surname>Aragam</surname> <given-names>KG</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name><name><surname>Barnard</surname> <given-names>J</given-names></name><name><surname>Bartz</surname> <given-names>TM</given-names></name><name><surname>Benjamin</surname> <given-names>EJ</given-names></name><name><surname>Bihlmeyer</surname> <given-names>NA</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Bloom</surname> <given-names>HL</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Bottinger</surname> <given-names>EB</given-names></name><name><surname>Brody</surname> <given-names>JA</given-names></name><name><surname>Calkins</surname> <given-names>H</given-names></name><name><surname>Campbell</surname> <given-names>A</given-names></name><name><surname>Cappola</surname> <given-names>TP</given-names></name><name><surname>Carlquist</surname> <given-names>J</given-names></name><name><surname>Chasman</surname> <given-names>DI</given-names></name><name><surname>Chen</surname> <given-names>LY</given-names></name><name><surname>Chen</surname> <given-names>YI</given-names></name><name><surname>Choi</surname> <given-names>EK</given-names></name><name><surname>Choi</surname> <given-names>SH</given-names></name><name><surname>Christophersen</surname> <given-names>IE</given-names></name><name><surname>Chung</surname> <given-names>MK</given-names></name><name><surname>Cole</surname> <given-names>JW</given-names></name><name><surname>Conen</surname> <given-names>D</given-names></name><name><surname>Cook</surname> <given-names>J</given-names></name><name><surname>Crijns</surname> <given-names>HJ</given-names></name><name><surname>Cutler</surname> <given-names>MJ</given-names></name><name><surname>Damrauer</surname> <given-names>SM</given-names></name><name><surname>Daniels</surname> <given-names>BR</given-names></name><name><surname>Darbar</surname> <given-names>D</given-names></name><name><surname>Delgado</surname> <given-names>G</given-names></name><name><surname>Denny</surname> <given-names>JC</given-names></name><name><surname>Dichgans</surname> <given-names>M</given-names></name><name><surname>DÃ¶rr</surname> <given-names>M</given-names></name><name><surname>Dudink</surname> <given-names>EA</given-names></name><name><surname>Dudley</surname> <given-names>SC</given-names></name><name><surname>Esa</surname> <given-names>N</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Eskola</surname> <given-names>M</given-names></name><name><surname>Fatkin</surname> <given-names>D</given-names></name><name><surname>Felix</surname> <given-names>SB</given-names></name><name><surname>Ford</surname> <given-names>I</given-names></name><name><surname>Franco</surname> <given-names>OH</given-names></name><name><surname>Geelhoed</surname> <given-names>B</given-names></name><name><surname>Grewal</surname> <given-names>RP</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Gustafsson</surname> <given-names>S</given-names></name><name><surname>Gutmann</surname> <given-names>R</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Heckbert</surname> <given-names>SR</given-names></name><name><surname>Hernesniemi</surname> <given-names>J</given-names></name><name><surname>Hocking</surname> <given-names>LJ</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Horimoto</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>PL</given-names></name><name><surname>Huffman</surname> <given-names>J</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Ipek</surname> <given-names>EG</given-names></name><name><surname>Ito</surname> <given-names>K</given-names></name><name><surname>Jimenez-Conde</surname> <given-names>J</given-names></name><name><surname>Johnson</surname> <given-names>R</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>KÃ¤Ã¤b</surname> <given-names>S</given-names></name><name><surname>KÃ¤hÃ¶nen</surname> <given-names>M</given-names></name><name><surname>Kamatani</surname> <given-names>Y</given-names></name><name><surname>Kane</surname> <given-names>JP</given-names></name><name><surname>Kastrati</surname> <given-names>A</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Katschnig-Winter</surname> <given-names>P</given-names></name><name><surname>Kavousi</surname> <given-names>M</given-names></name><name><surname>Kessler</surname> <given-names>T</given-names></name><name><surname>Kietselaer</surname> <given-names>BL</given-names></name><name><surname>Kirchhof</surname> <given-names>P</given-names></name><name><surname>Kleber</surname> <given-names>ME</given-names></name><name><surname>Knight</surname> <given-names>S</given-names></name><name><surname>Krieger</surname> <given-names>JE</given-names></name><name><surname>Kubo</surname> <given-names>M</given-names></name><name><surname>Launer</surname> <given-names>LJ</given-names></name><name><surname>Laurikka</surname> <given-names>J</given-names></name><name><surname>LehtimÃ¤ki</surname> <given-names>T</given-names></name><name><surname>Leineweber</surname> <given-names>K</given-names></name><name><surname>Lemaitre</surname> <given-names>RN</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Lim</surname> <given-names>HE</given-names></name><name><surname>Lin</surname> <given-names>HJ</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Lokki</surname> <given-names>ML</given-names></name><name><surname>London</surname> <given-names>B</given-names></name><name><surname>Loos</surname> <given-names>RJF</given-names></name><name><surname>Low</surname> <given-names>SK</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>LyytikÃ¤inen</surname> <given-names>LP</given-names></name><name><surname>Macfarlane</surname> <given-names>PW</given-names></name><name><surname>Magnusson</surname> <given-names>PK</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Malik</surname> <given-names>R</given-names></name><name><surname>Mansur</surname> <given-names>AJ</given-names></name><name><surname>Marcus</surname> <given-names>GM</given-names></name><name><surname>Margolin</surname> <given-names>L</given-names></name><name><surname>Margulies</surname> <given-names>KB</given-names></name><name><surname>MÃ¤rz</surname> <given-names>W</given-names></name><name><surname>McManus</surname> <given-names>DD</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Mohanty</surname> <given-names>S</given-names></name><name><surname>Montgomery</surname> <given-names>JA</given-names></name><name><surname>Morley</surname> <given-names>MP</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>MÃ¼ller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Natale</surname> <given-names>A</given-names></name><name><surname>Nazarian</surname> <given-names>S</given-names></name><name><surname>Neumann</surname> <given-names>B</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Niemeijer</surname> <given-names>MN</given-names></name><name><surname>Nikus</surname> <given-names>K</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Noordam</surname> <given-names>R</given-names></name><name><surname>Oellers</surname> <given-names>H</given-names></name><name><surname>Olesen</surname> <given-names>MS</given-names></name><name><surname>Orho-Melander</surname> <given-names>M</given-names></name><name><surname>Padmanabhan</surname> <given-names>S</given-names></name><name><surname>Pak</surname> <given-names>HN</given-names></name><name><surname>ParÃ©</surname> <given-names>G</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Pera</surname> <given-names>J</given-names></name><name><surname>Pereira</surname> <given-names>A</given-names></name><name><surname>Porteous</surname> <given-names>D</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Pulit</surname> <given-names>SL</given-names></name><name><surname>Pullinger</surname> <given-names>CR</given-names></name><name><surname>Rader</surname> <given-names>DJ</given-names></name><name><surname>Refsgaard</surname> <given-names>L</given-names></name><name><surname>RibasÃ©s</surname> <given-names>M</given-names></name><name><surname>Ridker</surname> <given-names>PM</given-names></name><name><surname>Rienstra</surname> <given-names>M</given-names></name><name><surname>Risch</surname> <given-names>L</given-names></name><name><surname>Roden</surname> <given-names>DM</given-names></name><name><surname>Rosand</surname> <given-names>J</given-names></name><name><surname>Rosenberg</surname> <given-names>MA</given-names></name><name><surname>Rost</surname> <given-names>N</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Saba</surname> <given-names>S</given-names></name><name><surname>Sandhu</surname> <given-names>RK</given-names></name><name><surname>Schnabel</surname> <given-names>RB</given-names></name><name><surname>Schramm</surname> <given-names>K</given-names></name><name><surname>Schunkert</surname> <given-names>H</given-names></name><name><surname>Schurman</surname> <given-names>C</given-names></name><name><surname>Scott</surname> <given-names>SA</given-names></name><name><surname>SeppÃ¤lÃ¤</surname> <given-names>I</given-names></name><name><surname>Shaffer</surname> <given-names>C</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Shalaby</surname> <given-names>AA</given-names></name><name><surname>Shim</surname> <given-names>J</given-names></name><name><surname>Shoemaker</surname> <given-names>MB</given-names></name><name><surname>Siland</surname> <given-names>JE</given-names></name><name><surname>Sinisalo</surname> <given-names>J</given-names></name><name><surname>Sinner</surname> <given-names>MF</given-names></name><name><surname>Slowik</surname> <given-names>A</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Smith</surname> <given-names>BH</given-names></name><name><surname>Smith</surname> <given-names>JG</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Smith</surname> <given-names>NL</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name><name><surname>Stricker</surname> <given-names>BH</given-names></name><name><surname>Sun</surname> <given-names>A</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Svendsen</surname> <given-names>JH</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Tanriverdi</surname> <given-names>K</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Teder-Laving</surname> <given-names>M</given-names></name><name><surname>Teumer</surname> <given-names>A</given-names></name><name><surname>ThÃ©riault</surname> <given-names>S</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>Tucker</surname> <given-names>NR</given-names></name><name><surname>Tveit</surname> <given-names>A</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Van Der Harst</surname> <given-names>P</given-names></name><name><surname>Van Gelder</surname> <given-names>IC</given-names></name><name><surname>Van Wagoner</surname> <given-names>DR</given-names></name><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>Vlachopoulou</surname> <given-names>E</given-names></name><name><surname>VÃ¶lker</surname> <given-names>U</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Weeke</surname> <given-names>PE</given-names></name><name><surname>Weijs</surname> <given-names>B</given-names></name><name><surname>Weiss</surname> <given-names>R</given-names></name><name><surname>Weiss</surname> <given-names>S</given-names></name><name><surname>Wells</surname> <given-names>QS</given-names></name><name><surname>Wiggins</surname> <given-names>KL</given-names></name><name><surname>Wong</surname> <given-names>JA</given-names></name><name><surname>Woo</surname> <given-names>D</given-names></name><name><surname>Worrall</surname> <given-names>BB</given-names></name><name><surname>Yang</surname> <given-names>PS</given-names></name><name><surname>Yao</surname> <given-names>J</given-names></name><name><surname>Yoneda</surname> <given-names>ZT</given-names></name><name><surname>Zeller</surname> <given-names>T</given-names></name><name><surname>Zeng</surname> <given-names>L</given-names></name><name><surname>Lubitz</surname> <given-names>SA</given-names></name><name><surname>Lunetta</surname> <given-names>KL</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multi-ethnic genome-wide association study for atrial fibrillation</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1225</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0133-9</pub-id><pub-id pub-id-type="pmid">29892015</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruijter</surname> <given-names>JM</given-names></name><name><surname>Ramakers</surname> <given-names>C</given-names></name><name><surname>Hoogaars</surname> <given-names>WM</given-names></name><name><surname>Karlen</surname> <given-names>Y</given-names></name><name><surname>Bakker</surname> <given-names>O</given-names></name><name><surname>van den Hoff</surname> <given-names>MJ</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Amplification efficiency: linking baseline and Bias in the analysis of quantitative PCR data</article-title><source>Nucleic Acids Research</source><volume>37</volume><elocation-id>e45</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkp045</pub-id><pub-id pub-id-type="pmid">19237396</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname> <given-names>JD</given-names></name><name><surname>Maeder</surname> <given-names>ML</given-names></name><name><surname>Reyon</surname> <given-names>D</given-names></name><name><surname>Voytas</surname> <given-names>DF</given-names></name><name><surname>Joung</surname> <given-names>JK</given-names></name><name><surname>Dobbs</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ZiFiT (Zinc finger targeter): an updated zinc finger engineering tool</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>W462</fpage><lpage>W468</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq319</pub-id><pub-id pub-id-type="pmid">20435679</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname> <given-names>MA</given-names></name><name><surname>Boyle</surname> <given-names>AP</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Batzoglou</surname> <given-names>S</given-names></name><name><surname>Snyder</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Linking disease associations with regulatory information in the human genome</article-title><source>Genome Research</source><volume>22</volume><fpage>1748</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1101/gr.136127.111</pub-id><pub-id pub-id-type="pmid">22955986</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Seidman</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Transcription factor haploinsufficiency: when half a loaf is not enough</article-title><source>Journal of Clinical Investigation</source><volume>109</volume><fpage>451</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1172/JCI0215043</pub-id><pub-id pub-id-type="pmid">11854316</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>R</given-names></name><name><surname>Hoogaars</surname> <given-names>WM</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Grieskamp</surname> <given-names>T</given-names></name><name><surname>Rana</surname> <given-names>MS</given-names></name><name><surname>Buermans</surname> <given-names>H</given-names></name><name><surname>Farin</surname> <given-names>HF</given-names></name><name><surname>Petry</surname> <given-names>M</given-names></name><name><surname>Heallen</surname> <given-names>T</given-names></name><name><surname>Martin</surname> <given-names>JF</given-names></name><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Kispert</surname> <given-names>A</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation</article-title><source>Cellular and Molecular Life Sciences</source><volume>69</volume><fpage>1377</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1007/s00018-011-0884-2</pub-id><pub-id pub-id-type="pmid">22130515</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name><name><surname>Isaacs</surname> <given-names>A</given-names></name><name><surname>de Bakker</surname> <given-names>PI</given-names></name><name><surname>DÃ¶rr</surname> <given-names>M</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Nolte</surname> <given-names>IM</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>MÃ¼ller</surname> <given-names>M</given-names></name><name><surname>Eijgelsheim</surname> <given-names>M</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Hicks</surname> <given-names>AA</given-names></name><name><surname>Padmanabhan</surname> <given-names>S</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Polasek</surname> <given-names>O</given-names></name><name><surname>Giovannone</surname> <given-names>S</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Magnani</surname> <given-names>JW</given-names></name><name><surname>Marciante</surname> <given-names>KD</given-names></name><name><surname>Pfeufer</surname> <given-names>A</given-names></name><name><surname>Gharib</surname> <given-names>SA</given-names></name><name><surname>Teumer</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Rivadeneira</surname> <given-names>F</given-names></name><name><surname>Aspelund</surname> <given-names>T</given-names></name><name><surname>KÃ¶ttgen</surname> <given-names>A</given-names></name><name><surname>Johnson</surname> <given-names>T</given-names></name><name><surname>Rice</surname> <given-names>K</given-names></name><name><surname>Sie</surname> <given-names>MP</given-names></name><name><surname>Wang</surname> <given-names>YA</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Fuchsberger</surname> <given-names>C</given-names></name><name><surname>Wild</surname> <given-names>SH</given-names></name><name><surname>Mateo Leach</surname> <given-names>I</given-names></name><name><surname>Estrada</surname> <given-names>K</given-names></name><name><surname>VÃ¶lker</surname> <given-names>U</given-names></name><name><surname>Wright</surname> <given-names>AF</given-names></name><name><surname>Asselbergs</surname> <given-names>FW</given-names></name><name><surname>Qu</surname> <given-names>J</given-names></name><name><surname>Chakravarti</surname> <given-names>A</given-names></name><name><surname>Sinner</surname> <given-names>MF</given-names></name><name><surname>Kors</surname> <given-names>JA</given-names></name><name><surname>Petersmann</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Munroe</surname> <given-names>PB</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Oostra</surname> <given-names>BA</given-names></name><name><surname>Cupples</surname> <given-names>LA</given-names></name><name><surname>Perz</surname> <given-names>S</given-names></name><name><surname>de Boer</surname> <given-names>RA</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>VÃ¶lzke</surname> <given-names>H</given-names></name><name><surname>Spector</surname> <given-names>TD</given-names></name><name><surname>Liu</surname> <given-names>FY</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Dominiczak</surname> <given-names>AF</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>van Herpen</surname> <given-names>G</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Wichmann</surname> <given-names>HE</given-names></name><name><surname>van Gilst</surname> <given-names>WH</given-names></name><name><surname>Witteman</surname> <given-names>JC</given-names></name><name><surname>Kroemer</surname> <given-names>HK</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Heckbert</surname> <given-names>SR</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Folsom</surname> <given-names>AR</given-names></name><name><surname>van Veldhuisen</surname> <given-names>DJ</given-names></name><name><surname>Schwienbacher</surname> <given-names>C</given-names></name><name><surname>O'Donnell</surname> <given-names>CJ</given-names></name><name><surname>Volpato</surname> <given-names>CB</given-names></name><name><surname>Caulfield</surname> <given-names>MJ</given-names></name><name><surname>Connell</surname> <given-names>JM</given-names></name><name><surname>Launer</surname> <given-names>L</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Fehrmann</surname> <given-names>RS</given-names></name><name><surname>te Meerman</surname> <given-names>G</given-names></name><name><surname>Groen</surname> <given-names>HJ</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Ophoff</surname> <given-names>RA</given-names></name><name><surname>Navis</surname> <given-names>G</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Snieder</surname> <given-names>H</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Pramstaller</surname> <given-names>PP</given-names></name><name><surname>Siscovick</surname> <given-names>DS</given-names></name><name><surname>Wang</surname> <given-names>TJ</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Felix</surname> <given-names>SB</given-names></name><name><surname>Fishman</surname> <given-names>GI</given-names></name><name><surname>Jamshidi</surname> <given-names>Y</given-names></name><name><surname>Stricker</surname> <given-names>BH</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>KÃ¤Ã¤b</surname> <given-names>S</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction</article-title><source>Nature Genetics</source><volume>42</volume><fpage>1068</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1038/ng.716</pub-id><pub-id pub-id-type="pmid">21076409</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanovic</surname> <given-names>S</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>van Duijvenboden</surname> <given-names>K</given-names></name><name><surname>Weber</surname> <given-names>D</given-names></name><name><surname>Gessler</surname> <given-names>M</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3680</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4680</pub-id><pub-id pub-id-type="pmid">24770533</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>van Setten</surname> <given-names>J</given-names></name><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>Vogler</surname> <given-names>G</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Mateo Leach</surname> <given-names>I</given-names></name><name><surname>Eijgelsheim</surname> <given-names>M</given-names></name><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Sorice</surname> <given-names>R</given-names></name><name><surname>Meirelles</surname> <given-names>O</given-names></name><name><surname>LyytikÃ¤inen</surname> <given-names>LP</given-names></name><name><surname>PolaÅ¡ek</surname> <given-names>O</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name><name><surname>Ulivi</surname> <given-names>S</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>MÃ¼ller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>DÃ¶rr</surname> <given-names>M</given-names></name><name><surname>Kerr</surname> <given-names>KF</given-names></name><name><surname>Magnani</surname> <given-names>JW</given-names></name><name><surname>Del Greco M</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Nolte</surname> <given-names>IM</given-names></name><name><surname>Silva</surname> <given-names>CT</given-names></name><name><surname>Padmanabhan</surname> <given-names>S</given-names></name><name><surname>Tragante</surname> <given-names>V</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Adriaens</surname> <given-names>ME</given-names></name><name><surname>Andersen</surname> <given-names>K</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Bodmer</surname> <given-names>R</given-names></name><name><surname>Buckley</surname> <given-names>BM</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Cannon</surname> <given-names>MV</given-names></name><name><surname>Chakravarti</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>LY</given-names></name><name><surname>Delitala</surname> <given-names>A</given-names></name><name><surname>Devereux</surname> <given-names>RB</given-names></name><name><surname>Doevendans</surname> <given-names>PA</given-names></name><name><surname>Dominiczak</surname> <given-names>AF</given-names></name><name><surname>Ferrucci</surname> <given-names>L</given-names></name><name><surname>Ford</surname> <given-names>I</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Haugen</surname> <given-names>E</given-names></name><name><surname>Heinig</surname> <given-names>M</given-names></name><name><surname>Hernandez</surname> <given-names>DG</given-names></name><name><surname>Hillege</surname> <given-names>HL</given-names></name><name><surname>Hirschhorn</surname> <given-names>JN</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Hubner</surname> <given-names>N</given-names></name><name><surname>Hwang</surname> <given-names>SJ</given-names></name><name><surname>Iorio</surname> <given-names>A</given-names></name><name><surname>KÃ¤hÃ¶nen</surname> <given-names>M</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Kolcic</surname> <given-names>I</given-names></name><name><surname>Kooner</surname> <given-names>IK</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Kors</surname> <given-names>JA</given-names></name><name><surname>Lakatta</surname> <given-names>EG</given-names></name><name><surname>Lage</surname> <given-names>K</given-names></name><name><surname>Launer</surname> <given-names>LJ</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Lundby</surname> <given-names>A</given-names></name><name><surname>Macfarlane</surname> <given-names>PW</given-names></name><name><surname>May</surname> <given-names>D</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Nappo</surname> <given-names>S</given-names></name><name><surname>Naitza</surname> <given-names>S</given-names></name><name><surname>Neph</surname> <given-names>S</given-names></name><name><surname>Nord</surname> <given-names>AS</given-names></name><name><surname>Nutile</surname> <given-names>T</given-names></name><name><surname>Okin</surname> <given-names>PM</given-names></name><name><surname>Olsen</surname> <given-names>JV</given-names></name><name><surname>Oostra</surname> <given-names>BA</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name><name><surname>Pennacchio</surname> <given-names>LA</given-names></name><name><surname>Pers</surname> <given-names>TH</given-names></name><name><surname>Perz</surname> <given-names>S</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Pinto</surname> <given-names>YM</given-names></name><name><surname>Pfeufer</surname> <given-names>A</given-names></name><name><surname>Pilia</surname> <given-names>MG</given-names></name><name><surname>Pramstaller</surname> <given-names>PP</given-names></name><name><surname>Prins</surname> <given-names>BP</given-names></name><name><surname>Raitakari</surname> <given-names>OT</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Rice</surname> <given-names>KM</given-names></name><name><surname>Rossin</surname> <given-names>EJ</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Schafer</surname> <given-names>S</given-names></name><name><surname>Schlessinger</surname> <given-names>D</given-names></name><name><surname>Schmidt</surname> <given-names>CO</given-names></name><name><surname>Sehmi</surname> <given-names>J</given-names></name><name><surname>SilljÃ©</surname> <given-names>HHW</given-names></name><name><surname>Sinagra</surname> <given-names>G</given-names></name><name><surname>Sinner</surname> <given-names>MF</given-names></name><name><surname>Slowikowski</surname> <given-names>K</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Spector</surname> <given-names>TD</given-names></name><name><surname>Spiering</surname> <given-names>W</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name><name><surname>Stolk</surname> <given-names>RP</given-names></name><name><surname>Strauch</surname> <given-names>K</given-names></name><name><surname>Tan</surname> <given-names>ST</given-names></name><name><surname>Tarasov</surname> <given-names>KV</given-names></name><name><surname>Trinh</surname> <given-names>B</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>van den Boogaard</surname> <given-names>M</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>van Gilst</surname> <given-names>WH</given-names></name><name><surname>Viikari</surname> <given-names>JS</given-names></name><name><surname>Visscher</surname> <given-names>PM</given-names></name><name><surname>Vitart</surname> <given-names>V</given-names></name><name><surname>VÃ¶lker</surname> <given-names>U</given-names></name><name><surname>Waldenberger</surname> <given-names>M</given-names></name><name><surname>Weichenberger</surname> <given-names>CX</given-names></name><name><surname>Westra</surname> <given-names>HJ</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Wolffenbuttel</surname> <given-names>BH</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Bezzina</surname> <given-names>CR</given-names></name><name><surname>Munroe</surname> <given-names>PB</given-names></name><name><surname>Snieder</surname> <given-names>H</given-names></name><name><surname>Wright</surname> <given-names>AF</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Boyer</surname> <given-names>LA</given-names></name><name><surname>Asselbergs</surname> <given-names>FW</given-names></name><name><surname>van Veldhuisen</surname> <given-names>DJ</given-names></name><name><surname>Stricker</surname> <given-names>BH</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Ciullo</surname> <given-names>M</given-names></name><name><surname>Sanna</surname> <given-names>S</given-names></name><name><surname>LehtimÃ¤ki</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Bandinelli</surname> <given-names>S</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Gasparini</surname> <given-names>P</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>KÃ¤Ã¤b</surname> <given-names>S</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Felix</surname> <given-names>SB</given-names></name><name><surname>Heckbert</surname> <given-names>SR</given-names></name><name><surname>de Boer</surname> <given-names>RA</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Hicks</surname> <given-names>AA</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Jamshidi</surname> <given-names>Y</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Isaacs</surname> <given-names>A</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>de Bakker</surname> <given-names>PIW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>52 genetic loci influencing myocardialÂ Mass</article-title><source>Journal of the American College of Cardiology</source><volume>68</volume><fpage>1435</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2016.07.729</pub-id><pub-id pub-id-type="pmid">27659466</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duijvenboden</surname> <given-names>K</given-names></name><name><surname>de Boer</surname> <given-names>BA</given-names></name><name><surname>Capon</surname> <given-names>N</given-names></name><name><surname>Ruijter</surname> <given-names>JM</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EMERGE: a flexible modelling framework to predict genomic regulatory elements from genomic signatures</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e42</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv1144</pub-id><pub-id pub-id-type="pmid">26531828</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duijvenboden</surname> <given-names>K</given-names></name><name><surname>de Bakker</surname> <given-names>DEM</given-names></name><name><surname>Man</surname> <given-names>JCK</given-names></name><name><surname>Janssen</surname> <given-names>R</given-names></name><name><surname>GÃ¼nthel</surname> <given-names>M</given-names></name><name><surname>Hill</surname> <given-names>MC</given-names></name><name><surname>Hooijkaas</surname> <given-names>IB</given-names></name><name><surname>van der Made</surname> <given-names>I</given-names></name><name><surname>van der Kraak</surname> <given-names>PH</given-names></name><name><surname>Vink</surname> <given-names>A</given-names></name><name><surname>Creemers</surname> <given-names>EE</given-names></name><name><surname>Martin</surname> <given-names>JF</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Bakkers</surname> <given-names>J</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conserved <italic>NPPB</italic>+ border zone switches from MEF2- to AP-1-Driven gene program</article-title><source>Circulation</source><volume>140</volume><fpage>864</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.038944</pub-id><pub-id pub-id-type="pmid">31259610</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eif</surname> <given-names>VWW</given-names></name><name><surname>Stefanovic</surname> <given-names>S</given-names></name><name><surname>van Duijvenboden</surname> <given-names>K</given-names></name><name><surname>Bakker</surname> <given-names>M</given-names></name><name><surname>Wakker</surname> <given-names>V</given-names></name><name><surname>de Gier-de Vries</surname> <given-names>C</given-names></name><name><surname>Zaffran</surname> <given-names>S</given-names></name><name><surname>Verkerk</surname> <given-names>AO</given-names></name><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptome analysis of mouse and human sinoatrial node cells reveals a conserved genetic program</article-title><source>Development</source><volume>146</volume><elocation-id>dev173161</elocation-id><pub-id pub-id-type="doi">10.1242/dev.173161</pub-id><pub-id pub-id-type="pmid">30936179</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Haelst</surname> <given-names>MM</given-names></name><name><surname>Monroe</surname> <given-names>GR</given-names></name><name><surname>Duran</surname> <given-names>K</given-names></name><name><surname>van Binsbergen</surname> <given-names>E</given-names></name><name><surname>Breur</surname> <given-names>JM</given-names></name><name><surname>Giltay</surname> <given-names>JC</given-names></name><name><surname>van Haaften</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Further confirmation of the MED13L haploinsufficiency syndrome</article-title><source>European Journal of Human Genetics</source><volume>23</volume><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2014.69</pub-id><pub-id pub-id-type="pmid">24781760</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Setten</surname> <given-names>J</given-names></name><name><surname>Brody</surname> <given-names>JA</given-names></name><name><surname>Jamshidi</surname> <given-names>Y</given-names></name><name><surname>Swenson</surname> <given-names>BR</given-names></name><name><surname>Butler</surname> <given-names>AM</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Del Greco</surname> <given-names>FM</given-names></name><name><surname>Evans</surname> <given-names>DS</given-names></name><name><surname>Gibson</surname> <given-names>Q</given-names></name><name><surname>Gudbjartsson</surname> <given-names>DF</given-names></name><name><surname>Kerr</surname> <given-names>KF</given-names></name><name><surname>Krijthe</surname> <given-names>BP</given-names></name><name><surname>LyytikÃ¤inen</surname> <given-names>LP</given-names></name><name><surname>MÃ¼ller</surname> <given-names>C</given-names></name><name><surname>MÃ¼ller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Nolte</surname> <given-names>IM</given-names></name><name><surname>Padmanabhan</surname> <given-names>S</given-names></name><name><surname>Ritchie</surname> <given-names>MD</given-names></name><name><surname>Robino</surname> <given-names>A</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Steri</surname> <given-names>M</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Teumer</surname> <given-names>A</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>Ulivi</surname> <given-names>S</given-names></name><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Arnar</surname> <given-names>DO</given-names></name><name><surname>Asselbergs</surname> <given-names>FW</given-names></name><name><surname>Bader</surname> <given-names>JS</given-names></name><name><surname>Barnard</surname> <given-names>J</given-names></name><name><surname>Bis</surname> <given-names>J</given-names></name><name><surname>Blankenberg</surname> <given-names>S</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Bradford</surname> <given-names>Y</given-names></name><name><surname>Buckley</surname> <given-names>BM</given-names></name><name><surname>Chung</surname> <given-names>MK</given-names></name><name><surname>Crawford</surname> <given-names>D</given-names></name><name><surname>den Hoed</surname> <given-names>M</given-names></name><name><surname>Denny</surname> <given-names>JC</given-names></name><name><surname>Dominiczak</surname> <given-names>AF</given-names></name><name><surname>Ehret</surname> <given-names>GB</given-names></name><name><surname>Eijgelsheim</surname> <given-names>M</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>Felix</surname> <given-names>SB</given-names></name><name><surname>Franco</surname> <given-names>OH</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Holm</surname> <given-names>H</given-names></name><name><surname>Ilaria</surname> <given-names>G</given-names></name><name><surname>Iorio</surname> <given-names>A</given-names></name><name><surname>KÃ¤hÃ¶nen</surname> <given-names>M</given-names></name><name><surname>Kolcic</surname> <given-names>I</given-names></name><name><surname>Kors</surname> <given-names>JA</given-names></name><name><surname>Lakatta</surname> <given-names>EG</given-names></name><name><surname>Launer</surname> <given-names>LJ</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Lin</surname> <given-names>HJ</given-names></name><name><surname>Loos</surname> <given-names>RJF</given-names></name><name><surname>Lubitz</surname> <given-names>SA</given-names></name><name><surname>Macfarlane</surname> <given-names>PW</given-names></name><name><surname>Magnani</surname> <given-names>JW</given-names></name><name><surname>Leach</surname> <given-names>IM</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Mitchell</surname> <given-names>BD</given-names></name><name><surname>Munzel</surname> <given-names>T</given-names></name><name><surname>Papanicolaou</surname> <given-names>GJ</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Pfeufer</surname> <given-names>A</given-names></name><name><surname>Pramstaller</surname> <given-names>PP</given-names></name><name><surname>Raitakari</surname> <given-names>OT</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Schlessinger</surname> <given-names>D</given-names></name><name><surname>Silva Aldana</surname> <given-names>CT</given-names></name><name><surname>Sinner</surname> <given-names>MF</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Snieder</surname> <given-names>H</given-names></name><name><surname>Soliman</surname> <given-names>EZ</given-names></name><name><surname>Spector</surname> <given-names>TD</given-names></name><name><surname>Stott</surname> <given-names>DJ</given-names></name><name><surname>Strauch</surname> <given-names>K</given-names></name><name><surname>Tarasov</surname> <given-names>KV</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Van Wagoner</surname> <given-names>DR</given-names></name><name><surname>VÃ¶lker</surname> <given-names>U</given-names></name><name><surname>VÃ¶lzke</surname> <given-names>H</given-names></name><name><surname>Waldenberger</surname> <given-names>M</given-names></name><name><surname>Jan Westra</surname> <given-names>H</given-names></name><name><surname>Wild</surname> <given-names>PS</given-names></name><name><surname>Zeller</surname> <given-names>T</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Avery</surname> <given-names>CL</given-names></name><name><surname>Bandinelli</surname> <given-names>S</given-names></name><name><surname>Benjamin</surname> <given-names>EJ</given-names></name><name><surname>Cucca</surname> <given-names>F</given-names></name><name><surname>DÃ¶rr</surname> <given-names>M</given-names></name><name><surname>Ferrucci</surname> <given-names>L</given-names></name><name><surname>Gasparini</surname> <given-names>P</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Heckbert</surname> <given-names>SR</given-names></name><name><surname>Hicks</surname> <given-names>AA</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>KÃ¤Ã¤b</surname> <given-names>S</given-names></name><name><surname>LehtimÃ¤ki</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Munroe</surname> <given-names>PB</given-names></name><name><surname>Parsa</surname> <given-names>A</given-names></name><name><surname>Polasek</surname> <given-names>O</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Roden</surname> <given-names>DM</given-names></name><name><surname>Schnabel</surname> <given-names>RB</given-names></name><name><surname>Sinagra</surname> <given-names>G</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Stricker</surname> <given-names>BH</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Gharib</surname> <given-names>SA</given-names></name><name><surname>de Bakker</surname> <given-names>PIW</given-names></name><name><surname>Isaacs</surname> <given-names>A</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name><name><surname>Sotoodehnia</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2904</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04766-9</pub-id><pub-id pub-id-type="pmid">30046033</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Weerd</surname> <given-names>JH</given-names></name><name><surname>Badi</surname> <given-names>I</given-names></name><name><surname>van den Boogaard</surname> <given-names>M</given-names></name><name><surname>Stefanovic</surname> <given-names>S</given-names></name><name><surname>van de Werken</surname> <given-names>HJ</given-names></name><name><surname>Gomez-Velazquez</surname> <given-names>M</given-names></name><name><surname>Badia-Careaga</surname> <given-names>C</given-names></name><name><surname>Manzanares</surname> <given-names>M</given-names></name><name><surname>de Laat</surname> <given-names>W</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A large permissive regulatory domain exclusively controls Tbx3 expression in the cardiac conduction system</article-title><source>Circulation Research</source><volume>115</volume><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303591</pub-id><pub-id pub-id-type="pmid">24963028</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>Mateo Leach</surname> <given-names>I</given-names></name><name><surname>van den Boogaard</surname> <given-names>M</given-names></name><name><surname>van Veldhuisen</surname> <given-names>DJ</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name><name><surname>Hillege</surname> <given-names>HL</given-names></name><name><surname>van Gilst</surname> <given-names>WH</given-names></name><name><surname>Barnett</surname> <given-names>P</given-names></name><name><surname>de Boer</surname> <given-names>RA</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><collab>LifeLines Cohort Study</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic determinants of P wave duration and PR segment</article-title><source>Circulation. Cardiovascular Genetics</source><volume>7</volume><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000373</pub-id><pub-id pub-id-type="pmid">24850809</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verweij</surname> <given-names>N</given-names></name><name><surname>van de Vegte</surname> <given-names>YJ</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic study links components of the autonomous nervous system to heart-rate profile during exercise</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>898</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03395-6</pub-id><pub-id pub-id-type="pmid">29497042</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tucker</surname> <given-names>NR</given-names></name><name><surname>Rizki</surname> <given-names>G</given-names></name><name><surname>Mills</surname> <given-names>R</given-names></name><name><surname>Krijger</surname> <given-names>PHL</given-names></name><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>Subramanian</surname> <given-names>V</given-names></name><name><surname>Bartell</surname> <given-names>E</given-names></name><name><surname>Nguyen</surname> <given-names>X-X</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name><name><surname>Leyton-Mange</surname> <given-names>J</given-names></name><name><surname>Dolmatova</surname> <given-names>EV</given-names></name><name><surname>van der Harst</surname> <given-names>P</given-names></name><name><surname>de Laat</surname> <given-names>W</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>Newton-Cheh</surname> <given-names>C</given-names></name><name><surname>Milan</surname> <given-names>DJ</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Boyer</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures</article-title><source>eLife</source><volume>5</volume><elocation-id>e10577</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10557</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabidi</surname> <given-names>MA</given-names></name><name><surname>Arnold</surname> <given-names>CD</given-names></name><name><surname>Schernhuber</surname> <given-names>K</given-names></name><name><surname>Pagani</surname> <given-names>M</given-names></name><name><surname>Rath</surname> <given-names>M</given-names></name><name><surname>Frank</surname> <given-names>O</given-names></name><name><surname>Stark</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Enhancer-core-promoter specificity separates developmental and housekeeping gene regulation</article-title><source>Nature</source><volume>518</volume><fpage>556</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1038/nature13994</pub-id><pub-id pub-id-type="pmid">25517091</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56697.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name><role>Reviewing Editor</role><aff><institution>University of Chicago</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name><role>Reviewer</role><aff><institution>University of Chicago</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Firulli</surname><given-names>Tony</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The manuscript presents an integrated approach for investigating genetic variation identified by GWAS, traveling from human genetics through informatics and genomic analysis to validation in a mouse model. This approach may be broadly applicable. Equally interesting are the specific findings concerning gene regulation at the TBX3 locus, including the identification of several enhancers, at least one of which is shown to be required in vivo.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Trait-associated noncoding variant regions affect <italic>TBX3</italic> regulation and cardiac conduction&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Ivan P Moskowitz as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Didier Stainier as the Senior Editor The following individual involved in review of your submission has agreed to reveal their identity: Tony Firulli (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>Summary:</p><p>Hendrik van Weerd et. al is a very good manuscript detailing a functional genomics approach to understanding regulation of the TBX3 gene and investigating GWAS variants for cardiac rhythm traits at the TBX3 locus. The paper includes an interrogation of common non-coding genomic variants upstream and in cis with the T-box transcription factor TBX3 associated with changes in cardiac conduction velocity.</p><p>The paper excels in several ways. First, it provides a comprehensive approach to travel from trait-associated variants to functional investigation of the gene regulatory consequences of specific variants, attempting to link them to phenotypic consequences. Second, it advances our understanding of the cis-regulatory landscape at TBX3 and reveals a likely molecular mechanism for GWAS signals at the TBX3 locus â specifically, variation of cis-regulatory element function affecting TBX3 expression in conduction tissues. Third, it considers and tackles some basic difficulties in understanding cardiac conduction system GWAS â the lack of human expression data for cardiac conduction tissues and therefore the lack of eQTL data for such tissues implicated in cardiac rhythm control. The mouse â human pipeline presented provides a potential roadmap for future studies in the CCS or in other tissues that lack human expression data.</p><p>Revisions:</p><p>The specific comments are meant to clarify the manuscript. The generation of new data is not necessary for the revision. The following issues should to be clarified in a revision manuscript, either by analysis of current data or by clarification of the text and/or figures:</p><p>1) In-vivo functional analysis is not of SNPs themselves but of a much larger enhancer deletion. This caveat should be discussed with regards to the molecular mechanism underlying the GWAS association caused by SNPs.</p><p>2) Some of the observed molecular and functional effects of SNPs or enhancer knockouts are unexpected and are left without a mechanistic explanation. For example, analysis of the in-vivo effects of removal of VR2 generated results for Tbx3 expression and for functional conduction measures that are opposite of expectations. Tbx3, a repressor of fast conduction channels, was upregulated in conduction tissues, generating the expectation that conduction would be slowed in affected regions. However, a decreased PR interval, indicative of more rapid conduction speed, was observed. Can the authors explain why this is the case? At the very least the authors should discuss the unexpected nature of this observation and offer a plausible explanation.</p><p>3) The Motif data presented in a few of the figures may not be accurate. It is clear that the VR2 is functional and published DNA occupancy data shows associated DNA binding from defined TFs within the RE's; however, the sequence consensus shown for the bHLH factors (sans MyoD) do not contain E-boxes, <italic>SOX9</italic> and SMAD Motifs reported also appear non-canonical. Discussing this at some level is warranted.</p><p>4) ATAC-seq was performed in embryonic hearts and traits were from adult humans. This comparison may underestimate the overlap were ATAC to be done on adult AVC cells. This caveat should be discussed.</p><p>5) The authors interrogated the human TBX3 locus for TAD structure and the location of SNPs associated with conduction traits; they identified candidate REs in the AVC by performing AVC ATAC-seq, which should provide an excellent resource for the field.</p><p>How were the 67 candidate REs at the Tbx3 locus defined relative to the entire dataset?</p><p>How specific are the identified elements for the AVC as opposed to non-AVC myocardium?</p><p>The authors show but do not discuss the comparison between the AVC versus ventricular ATAC across the Tbx3 locus. How many are AVC-specific? It looks like many are shared.</p><p>Did the author's attempt a differential ATAC analysis across the locus?</p><p>6) The STARR analysis was performed in COS cells to identify regions that activate transcription based on specific TFs previously defined as important for AVC gene expression. As the authors indicate, there is no AVC cell line, requiring use of an unrelated line. None-the-less, the use of COS cells is a significant caveat, and should be discussed clearly in the Discussion. The TF enrichment in this context is a therefore a self-fulfilling prophecy.</p><p>The number of human and mouse STARR identified candidates, as well as their overlap, should be described up front.</p><p>7) The description of mouse/human homology for VR1 and VR2 should be described in more detail.</p><p>8) RE candidate selection is described in Fg3a using a hierarchical approach in schematic form.</p><p>It should be possible to use the actual locus, display the individual datasets, and overlay them to present a more accurate description of the chosen REs at the locus.</p><p>Figure 3B appears to display data already published. Were any other candidates tested in-vivo?</p><p>9) Several of the candidate risk alleles, examined in luciferase activity in Figure 4C and d, show discordant effects on basal activity and TF-stimulated activity. This should be described and considered. Do the variants alter TF binding sites of known activator or repressor TFs that would help explain this discordance? Do any of the analyzed variants alter TF binding sites of the TF analyzed, which may explain their altered regulatory response to TF expression?</p><p>10) In Figure 6, the schematic shows the location of the TALEN cuts. The authors should delineate VR1 and VR2, as in Figure 5.</p><p>11) Figure 1C do the authors have insight as to why the Motif consensus for HAND2, TCF3, and TCF4 do not contain a clear E-box motif such as shown for MyoD? The <italic>SOX9</italic> Motif also seems out of place with the canonical consensus: CCTTGAG. SMAD 3&amp;4 likewise are reported to bind CAGAC, CAGCC as well as the 5-bp consensus sequence GGC(GC)|(CG). What is shown in the motif is very different and some discussion of this is warranted there is not confidence that the aforementioned transcription factors would bind these sequences robustly. There is simply low confidence that the algorithm is pulling accurate motif data and the authors should try to address this in the text.</p><p>12) Figure 2 same issue with consensus data in 2G (note the motif name and the motif do not line up correctly).</p><p>13) Figure 3 some clarity in the narration would be helpful. Paragraph one of subsection âIdentification of variant REs within VR1 and VR2â discuss 9 candidate REs in VR1 and 13 in VR2. Are these regions supposed to be identifiable in Figure 3A (as is the assumption)? The figure shows 6 candidate REs which resolve to 3 with SNP overlaps comparing the figure to the narration is confusing.</p><p>14) Figure 6C shows only Tbx3 expression Tbx5 and Med13l expression narrated as being in Figure 6C. Panel G would benefit from slightly enlarged images.</p><p>15) The criteria and datasets used to define the EMERGE regions is not found in this paper nor is there any citation listing where these regions came from. Please clarify.</p><p>16) What was the criteria used to identify the 9 and 13 (as listed in the text) candidate regulatory elements in VR1/2? Supplementary Table 4 lists only 20 candidate regulatory elements (7 and 13). What happened to hRE1 and hRE2 to exclude them from downstream analysis and inclusion in the table? Were other sites excluded as well? It is also unclear from Figures 2H-K and Figure 3A, and Supplementary Tables 3 and 4 what was used to define the candidate regulatory elements examined in greater detail in Figures 4, Figure 3âfigure supplement 1 and Figure 4âfigure supplement 1. For example, hRE13 was not examined in Figures 4C/D or Figure 4âfigure supplement 1. Overall, I really like the multi-factor approach to defining candidates; however, the key filtering steps taken to get the final list of candidates needs to be more clearly defined.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56697.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Revisions:</p><p>The specific comments are meant to clarify the manuscript. The generation of new data is not necessary for the revision. The following issues should to be clarified in a revision manuscript, either by analysis of current data or by clarification of the text and/or figures:</p><p>1) In-vivo functional analysis is not of SNPs themselves but of a much larger enhancer deletion. This caveat should be discussed with regards to the molecular mechanism underlying the GWAS association caused by SNPs.</p></disp-quote><p>We agree and have elaborated in the Discussion: âOur current findings further substantiate regulatory redundancy in vivo. [â¦] Therefore, we set out to assess the effect of deletion of the entire variant regions within the TBX3 locus rather than assessing the effect of individual SNPs, and found that the two TBX3 risk loci harbor multiple active REs whose activity is affected by their respective risk alleles.â</p><disp-quote content-type="editor-comment"><p>2) Some of the observed molecular and functional effects of SNPs or enhancer knockouts are unexpected and are left without a mechanistic explanation. For example, analysis of the in-vivo effects of removal of VR2 generated results for Tbx3 expression and for functional conduction measures that are opposite of expectations. Tbx3, a repressor of fast conduction channels, was upregulated in conduction tissues, generating the expectation that conduction would be slowed in affected regions. However, a decreased PR interval, indicative of more rapid conduction speed, was observed. Can the authors explain why this is the case? At the very least the authors should discuss the unexpected nature of this observation and offer a plausible explanation.</p></disp-quote><p>We agree the result was unexpected. Reduction of Tbx3 also results in PR shortening (Frank et al., 2012), suggesting that both more and less than normal Tbx3 causes apparent faster conduction through the AV conduction system. While several channels and gap junction subunits that are also targets of Tbx3 have been indicated to dose dependently contribute to conduction (Scn5a/Nav1.5, Gja5/Cx40 etc.), many more genes will be deregulated in the mutant AV conduction system, leading to changes in a complex genetic network with currently unpredictable output. We have discussed this in the Discussion section, also referring to recent work from the Moskowitz lab regarding the interplay between Tbx5 and Tbx3 in the AV bundle.</p><p>âNot only Tbx3 insufficiency (Bakker et al., 2008; Frank et al., 2011; Horsthuis et al., 2009) but also over-expression (this study, Burnicka-Turek et al., 2020) can be detrimental, suggesting proper AVCS function depends on strictly balanced Tbx3 levels. [â¦] Further studies are required to unravel the mechanisms through which <italic>Tbx3</italic> dose influences the AVCS gene regulatory network and PR interval or QRS duration.â</p><disp-quote content-type="editor-comment"><p>3) The Motif data presented in a few of the figures may not be accurate. It is clear that the VR2 is functional and published DNA occupancy data shows associated DNA binding from defined TFs within the RE's; however, the sequence consensus shown for the bHLH factors (sans MyoD) do not contain E-boxes, SOX9 and SMAD Motifs reported also appear non-canonical. Discussing this at some level is warranted.</p></disp-quote><p>We agree with the reviewer, and have specified interpretations of the Motif analysis. The confidence of such analyses depends on the quality of motifs within the database, which are experimentally derived from different experiments, in various cell types or developmental stages. As such, scanning sequences for motif enrichment using HOMER or other large scale analysis tools should be interpreted with this in mind. Nevertheless, we used the analysis to obtain a global impression of the factors that could be involved in AVCS Tbx3 regulation, while being aware that the output list is far from comprehensive. We have toned down statements regarding the conclusion of this analysis in the Results and Discussion section, and have specified in the Discussion that we used this analysis mainly to obtain an impression of involved factors, and have discussed the caveats of this analysis. Furthermore, we have removed the motif logos from Figure 1C.</p><disp-quote content-type="editor-comment"><p>4) ATAC-seq was performed in embryonic hearts and traits were from adult humans. This comparison may underestimate the overlap were ATAC to be done on adult AVC cells. This caveat should be discussed.</p></disp-quote><p>We agree with the reviewer that we might underestimate the overlap of GWAS-SNPs with potential REs, as we do not include adult AVC ATAC-seq in our analysis. However, we assume that a large proportion of the potential regulatory elements accessible in adult tissues are also accessible at developmental stages. The embryonic ATAC-seq data is furthermore only one of the filtering steps for selecting candidate REs, as we also use mouse and human STARR-seq, and mouse and human EMERGE prediction, which is based on multiple datasets including some derived from adult mouse tissues and human tissues. Nevertheless, including ATAC-seq data derived from adult Tbx3+ hearts could yield additional regulatory elements that are potentially missed in this configuration and we have added this limitation to the Conclusion.</p><disp-quote content-type="editor-comment"><p>5) The authors interrogated the human TBX3 locus for TAD structure and the location of SNPs associated with conduction traits; they identified candidate REs in the AVC by performing AVC ATAC-seq, which should provide an excellent resource for the field.</p><p>How were the 67 candidate REs at the Tbx3 locus defined relative to the entire dataset?</p><p>How specific are the identified elements for the AVC as opposed to non-AVC myocardium?</p><p>The authors show but do not discuss the comparison between the AVC versus ventricular ATAC across the Tbx3 locus. How many are AVC-specific? It looks like many are shared.</p><p>Did the author's attempt a differential ATAC analysis across the locus?</p></disp-quote><p>To increase specificity and minimize the risk of unjustly excluding potential accessible regions for downstream analysis, we used a local threshold value for our selection of ATAC-AVJ regions. We observed that, even with less stringent parameters, genome-wide peak-calling algorithms did not fully call all peaks (we are aware that this observation was done by visually inspecting the ATAC-seq track in the murine <italic>Tbx3</italic> locus and that it is therefore subjective). As such, we used a local, locus-specific threshold value for the selection of peaks â the entire sequence surpassing the threshold was included and considered as potential RE. A similar approach was used to select ventricle ATAC-peaks, and a random selection of 67 regions from this set was used for the motif enrichment analysis.</p><p>From these 67 accessible fetal AVCS regions, 28 overlapped with accessible adult ventricular regions, indeed a fair share of overlap. We have added this to Figure 1. This large portion of overlap can be explained by the fact that although AVCS and ventricle are distinct cell types, both are types of cardiomyocytes and therefore potentially share multiple transcription factors or regulatory machinery components that bind to their genomic location. We tried performing the analysis on regions only accessible in either AVCS or ventricle, however, the number of input regions was too low and underpowered. Furthermore, we note that the previously identified AVCS-specific enhancers Tbx3-eA and Tbx3-eB are accessible in multiple cell types, including our AVCS and ventricle ATAC-seq datasets, yet show highly specific activity in only the AVCS. Excluding regions that are also accessible in the ventricle dataset, or only focusing on the AVCS-specific regions, would omit such potentially strong RE candidates from further analysis. We have included and expanded the Materials and methods section to elaborate more on the inclusion criteria for ATAC peaks and their downstream analysis.</p><disp-quote content-type="editor-comment"><p>6) The STARR analysis was performed in COS cells to identify regions that activate transcription based on specific TFs previously defined as important for AVC gene expression. As the authors indicate, there is no AVC cell line, requiring use of an unrelated line. None-the-less, the use of COS cells is a significant caveat, and should be discussed clearly in the Discussion. The TF enrichment in this context is a therefore a self-fulfilling prophecy.</p><p>The number of human and mouse STARR identified candidates, as well as their overlap, should be described up front.</p></disp-quote><p>We have edited the Results section according to the reviewerâs suggestion and moved the description on the number of human and mouse STARR REs, and their overlap, up front. We have revised Figure 2 accordingly.</p><p>We agree with the reviewerâs comments regarding the caveat of using the COS7 cell line for the identification of AVCS-specific regulatory elements. However, in the experiments described in this manuscript, the high transfection efficiency of the COS7 cells allowed us to reach high resolution in the STARR-seq output, which requires large numbers of transfected cells. Indeed, due to low transfection efficiencies, STARR-seq in âatrialâ HL1 cells failed. The lack of a non-AVCS-myocardium gene program allowed us to specifically focus on the response of regions in the murine/human TBX3 locus to SG4 or Wnt factors.</p><p>The TF enrichment for the respective stimuli could indeed be seen as a self-fulfilling prophecy. However, the aim of this exercise was to validate the cutoff for regulatory activity rather than identify motifs specifically present in these regions, in other words: to see if we, with a rather low threshold for regulatory activity of FC&gt;1.5 would still extract relevant sequences while minimizing the change to falsely exclude regions. As such, we wanted to assess whether the active regions we identified with the FC&gt;1.5 threshold would yield relevant sequences, rather than noise caused by inter-experiment variation. Indeed, we found that the active regions in the respective STARR datasets were enriched for binding motifs of the respective factors that we co-transfected the libraries with, indicating the used threshold was justified.</p><p>We have revised the Discussion and included some discussion regarding the use of COS-7 cells and the potential caveats. Furthermore, we have revised the Discussion on the interpretation and use of the binding motif enrichment analysis according to the reviewerâs comments, also in line with the question of reviewer 2.</p><disp-quote content-type="editor-comment"><p>7) The description of mouse/human homology for VR1 and VR2 should be described in more detail.</p></disp-quote><p>We have added a track displaying sequence conservation in the mouse and human genomes, respectively, to Figure 5, and have added information regarding the sequence homology between mouse and human VR1 and VR2 in the Results section. VR2 also harbors the AVC-specific RE that was functionally and structurally conserved between mouse and human.</p><disp-quote content-type="editor-comment"><p>8) RE candidate selection is described in Fg3a using a hierarchical approach in schematic form.</p><p>It should be possible to use the actual locus, display the individual datasets, and overlay them to present a more accurate description of the chosen REs at the locus.</p><p>Figure 3B appears to display data already published. Were any other candidates tested in-vivo?</p></disp-quote><p>We agree with the reviewer that the use of the actual locus with the respective datasets would provide a more accurate description of the workflow, and, more importantly, of the filtering/inclusion steps at each step. We have discarded the schematic illustration of the former Figure 3 and revised the figure to show the actual datasets for each step, being: 1) hSTARR-seq data with final regions; 2) human EMERGE predicted enhancers; and 3) mouse orthologous RE candidates, based on fetal AVCS-ATAC-seq and mouse EMERGE enhancer prediction, translated to the human genome. The figure now also shows which regions have been included for downstream analysis at each step.</p><p>The LacZ-stained heart showing reporter activity driven by Tbx3-eA from Figure 3B has indeed been published previously, and as such we omitted it from the figure. We believe that the message of this panel, to show that this region (and previously identified Tbx3-eB, not shown here) was marked in all datasets used throughout the pipeline, serves as a validation of our approach and as such we kept the genome browser view of this region and moved it to the Figure 3âfigure supplement 1. We did not test other RE candidates in vivo.</p><disp-quote content-type="editor-comment"><p>9) Several of the candidate risk alleles, examined in luciferase activity in Figure 4C and D, show discordant effects on basal activity and TF-stimulated activity. This should be described and considered. Do the variants alter TF binding sites of known activator or repressor TFs that would help explain this discordance? Do any of the analyzed variants alter TF binding sites of the TF analyzed, which may explain their altered regulatory response to TF expression?</p></disp-quote><p>We have added a short paragraph to the Discussion on the discordant direction of effect of variant REs on basal activity and SG4- or Tcf-stimulated activity. âSeveral of the tested risk alleles (e.g. hRE8, hRE9, hRE18) showed a discordant direction of effect between basal activity in COS-7/HL1 and SG4-/Wnt-stimulated activity. This observation suggests that potentially multiple factors act on these variant REs, with SG4- or Tcf factors counteracting the effect of regulatory networks active in COS-7 or HL1 cells. Although we could not identify specific TF binding motifs affected by the respective SNPs in these REs, studying TF occupancy in more detail specifically in AVCS cells could elaborate on the precise mechanisms through which these variant REs act.â</p><p>Furthermore, we have analyzed whether the variants in the tested REs disrupt or create transcription factor binding sites using JASPAR. To this end, we took the variant nucleotide and 10 nucleotides both up- and downstream, and used these 21bp sequences as input for transcription factor binding motif recognition in JASPAR using default settings. We did not find any disrupted or de novo created binding motifs this way, although we are aware that the JASPAR binding motif database is incomplete and/or inaccurate as described below (#11). We also manually analyzed the variant REs for disrupted/de novo created binding motifs, e.g. T-box/E-box motifs, but did not find any. We have added this to the Results section and added a paragraph in the Discussion section.</p><disp-quote content-type="editor-comment"><p>10) In Figure 6, the schematic shows the location of the TALEN cuts. The authors should delineate VR1 and VR2, as in Figure 5.</p></disp-quote><p>We edited Figure 6 such that it shows the location of VR1 and VR2, additional to the location of the CRISPR/TALEN deletion sites according to the reviewerâs suggestion.</p><disp-quote content-type="editor-comment"><p>11) Figure 1C do the authors have insight as to why the Motif consensus for HAND2, TCF3, and TCF4 do not contain a clear E-box motif such as shown for MyoD? The SOX9 Motif also seems out of place with the canonical consensus: CCTTGAG. SMAD 3&amp;4 likewise are reported to bind CAGAC, CAGCC as well as the 5-bp consensus sequence GGC(GC)|(CG). What is shown in the motif is very different and some discussion of this is warranted there is not confidence that the aforementioned transcription factors would bind these sequences robustly. There is simply low confidence that the algorithm is pulling accurate motif data and the authors should try to address this in the text.</p></disp-quote><p>We agree with the reviewer, and have specified interpretations of the Motif analysis. The confidence of such analyses depends on the quality of motifs within the database, which are experimentally derived by different experiments, in various cell types or developmental stages. As such, scanning sequences for motif enrichment using HOMER or other large scale analysis tools should be interpreted with this in mind. Nevertheless, we used the analysis to obtain a global impression of the factors that could be involved in AVCS Tbx3 regulation, while being aware that the output list is far from comprehensive. We have toned down statements regarding the conclusion of this analysis in the Results and Discussion section, and have specified in the Discussion that we used this analysis mainly to obtain an impression of involved factors, and have discussed the caveats of this analysis. Furthermore, we have removed the motif logos from Figure 1C.</p><disp-quote content-type="editor-comment"><p>12) Figure 2 same issue with consensus data in 2G (note the motif name and the motif do not line up correctly).</p></disp-quote><p>Similar to the response to the question above, we have removed the motif logos from Figure 2G and corrected the misalignment of motif name and p-value. Furthermore, similarly to the clarification to the previous question, we have discussed in the manuscript that the motif analysis here was done primarily to see if the regulatory activity of the identified STARR-seq regions indeed correlated with enrichment of motifs for the respective co-transfected factors, rather than to identify novel factors.</p><disp-quote content-type="editor-comment"><p>13) Figure 3 some clarity in the narration would be helpful. Paragraph one of subsection âIdentification of variant REs within VR1 and VR2â discuss 9 candidate REs in VR1 and 13 in VR2. Are these regions supposed to be identifiable in Figure 3A (as is the assumption)? The figure shows 6 candidate REs which resolve to 3 with SNP overlaps comparing the figure to the narration is confusing.</p></disp-quote><p>We agree with the reviewer that the narration in this figure might be unclear. Figure 3 served as simplified example to illustrate the workflow we used to identify regulatory elements within VR1 and VR2. As such, the regions shown in Figure 3 do not depict the true REs we identified in this manuscript. We have revised this figure and used the actual data to illustrate the workflow, simultaneously showing which regions have been included for downstream analysis at each step.</p><disp-quote content-type="editor-comment"><p>14) Figure 6C shows only Tbx3 expression Tbx5 and Med13l expression narrated as being in Figure 6C. Panel G would benefit from slightly enlarged images.</p></disp-quote><p>We have corrected the text to include the notion that expression levels of Tbx5 and Med13l have been measured but are not shown in Figure 6C. Furthermore, we have enlarged panel G for clarity, following the reviewerâs suggestion.</p><disp-quote content-type="editor-comment"><p>15) The criteria and datasets used to define the EMERGE regions is not found in this paper nor is there any citation listing where these regions came from. Please clarify.</p></disp-quote><p>We have added a paragraph in the Materials and methods section describing the use of EMERGE for the prediction of regulatory elements in both the mouse and human genome. Furthermore, we have added Supplementary Tables 10 and 11 to Supplementary file 1, listing the datasets used by EMERGE to generate a genome-wide prediction track of cardiac enhancers in both the mouse and human genome.</p><disp-quote content-type="editor-comment"><p>16) What was the criteria used to identify the 9 and 13 (as listed in the text) candidate regulatory elements in VR1/2? Supplementary Table 4 lists only 20 candidate regulatory elements (7 and 13). What happened to hRE1 and hRE2 to exclude them from downstream analysis and inclusion in the table? Were other sites excluded as well? It is also unclear from Figures 2H-K and Figure 3A, and Supplementary Tables 3 and 4 what was used to define the candidate regulatory elements examined in greater detail in Figures 4, Figure 3âfigure supplement 1 and S3. For example, hRE13 was not examined in Figures 4C/D or Figure 4âfigure supplement 1. Overall, I really like the multi-factor approach to defining candidates; however, the key filtering steps taken to get the final list of candidates needs to be more clearly defined.</p></disp-quote><p>We have edited Figure 3, and used the actual <italic>TBX3</italic> locus and data to illustrate the pipeline and the filtering steps that were used to identify candidate REs. Potential regulatory elements have been identified throughout the entire human <italic>TBX3</italic> locus, based on the three approaches/filtering steps shown in revised Figure 3: 1) human STARR-seq activity, 2) human EMERGE enhancer prediction, and 3) mouse orthologous RE candidate regions, based on fetal AVCS-ATAC-seq and mouse EMERGE, translated to the human genome. We then looked at which of these regions were located within VR1 or VR2, and included these regions in Supplementary file 1âSupplementary Table 4. These regions were then overlapped with the GWAS SNPs for PR interval and QRS duration, and the REs overlapping one or more of these SNPs were used for variant haplotype activity testing using transfection/luciferase assays. We have revised the text accordingly to correspond to the revised figure, and hope that this revision clarifies the filtering steps we used to obtain the final list of RE candidates.</p><p>hRE1 and hRE2 were initially included as potential regulatory elements. However, their genomic location was outside the set boundaries of VR1 for final downstream analysis and inclusion â we have corrected the manuscript accordingly, stating that 7 and 13 REs have been identified in VR1 and VR2, respectively.</p><p>Due to technical issues we failed to amplify and clone hRE13 from the genomes of the human haplotypes we used. We have added this notion to the manuscript.</p></body></sub-article></article>